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Our sensory systems allow us to detect and successfully navigate the 
environment. The visual system translates environmental light into our conscious 
perception of sight, as well as subconscious physiological responses such as circadian 
photoentrainment, the pupillary light reflex, and mood modulation among others. The 
first step in these processes is photon detection by photoreceptors in the neural retina of 
the eye. In mammals, 3 general classes of photoreceptors exist: rods, cones, and 
intrinsically photosensitive retinal ganglion cells (ipRGCs). ipRGCs, in addition to being 
photoreceptors, are the critical relay for light information from rods and cones to brain 
areas responsible for the subconscious responses to light. In order for this light 
information to get to the brain, ipRGCs are known to employ 2 distinct neurotransmitters: 
glutamate and PACAP. However, the contribution of each photoreceptor and 
neurotransmitter to subconscious behaviors remains unclear. In this thesis, I demonstrate 
the role each photoreceptor plays in responding to the multitude of potential 
environmental light conditions. I show, similar to the photoreceptors, the 
neurotransmitters relay distinct and necessary aspects of the information detected by the 
photoreceptors. In addition, I identify novel neurotransmitters within subsets of ipRGCs 
which may be responsible for relaying their own unique aspect of the light environment 
to the brain. 
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I want to start with a general introduction to the system I have worked on for the 
past 5 years. This chapter is simply to provide a framework for the questions I will be 
asking in the subsequent chapters. More detailed information can be found in the 
introductions to each experimental chapter. 
 
Light and animal behavior 
 All organisms rely on their sensory systems to navigate and interact with the 
environment. In mammals, vision, smell, hearing, touch, and taste are our most readily 
recognizable sensory systems. Each sensory system detects and translates a particular 
aspect of the environment into conscious perception as well as subconscious 
physiological responses. For instance, the visual system relies on photons to generate the 
percept of sight and subconsciously regulate activity, pupil size, mood, and sleep among 
a variety of other physiological processes.  
 The visual system faces an environment with an incredible range of light 
conditions. Over the course of a typical day and night, ambient light intensity can vary by 
more than 100 million-fold (0.001 lux to 200,000 lux by my own measurements). In 
addition to intensity, the wavelengths of the photons making up light, or spectral 
composition, in the environment changes. In humans, we can detect photons ranging 
from ~390nm to ~760nm1. Our visual system’s ability to discriminate between photons of 
different wavelengths is the basis of our perception of color. 
 While conscious visual perception is the most easily appreciated function of the 
visual system, it also coordinates a multitude of critical processes subconsciously. 
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Among these, some of the most well studied are circadian photoentrainment, the 
pupillary light reflex, and mood and sleep modulation2. The system supporting 
subconscious visual responses, namely the pupillary light reflex, has been the focus of 
my thesis work. 
   
The eye and the retina 
 The eye is the sensory organ of the visual system. It has three primary 
components: the pupil, the lens, and the retina. Its construction is remarkably similar to 
that of a modern man-made camera. First, the pupil is analogous to a camera’s aperture, it 
regulates the amount of light entering the system. The lens of the eye and the camera 
serve to focus the light into a coherent image on the photodetector. For cameras that 
photodetector is likely film or a photosensitive chip – the retina serves this purpose in our 
eyes. 
The retina is a neural tissue that lines the back of the eye and consists of 6 general 
classes of neuron: the classical photoreceptors (rods and cones), horizontal cells, 
amacrine cells, bipolar cells, and retinal ganglion cells. Most of these classes of neurons 
have many subtypes within that class making the retina an incredibly diverse and 
complex tissue. 
Importantly, only the photoreceptors sense photons. The other neuronal cell types 
and subtypes function to modulate, process, and relay the information gathered at the 
photoreceptors to the brain. 




 The classical photoreceptors make up the outermost layer of the retina (the 
furthest from the center of the eye)3. The two types of photoreceptor, rods and cones, 
differ considerably in morphology and function. Rods provide the basis for our incredibly 
high sensitivity low-light vision while cones support vision during daylight as well as 
color perception in humans.  
 One reason rods and cones differ functionally is because they express a different 
cohort of proteins. Most notably, they express different photosensitive proteins called 
opsins – rods express the opsin named Rhodopsin and cones express one of the cone 
opsins3. These proteins impart photosensitivity onto photoreceptors by activating a 
signaling cascade in response to being struck by a photon. For rods and cones, opsin 
activation counterintuitively reduces photoreceptor activity. This photoreceptor activity 
modulation by light is subsequently relayed to the other retinal cell types and eventually 
reaches the brain. 
 Until recently, these classical photoreceptors were thought to be the sole source of 
light information for all visual responses – conscious perception and subconscious 
responses. Work in the late 1990s and early 2000s revealed a novel photoreceptor unlike 
either rods or cones4–11. These cells are a subtype of retinal ganglion cell subsequently 
named intrinsically photosensitive retinal ganglion cell or ipRGC. Retinal ganglion cells, 
RGCs, reside in the innermost layer of the retina and are the sole output neurons of the 
retina; they provide the only conduit for retinal information to the brain. Like other 
RGCs, ipRGCs receive and relay light information from rods and cones to the brain, but 
unlike other RGCs, ipRGCs are themselves photosensitive by expression of the 
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photosensitive protein Melanopsin (Opn4). Thus, ipRGCs serves both as a light relay and 
a light sensor and must integrate these two modalities. 
Remarkably, it was found that ipRGCs provide exclusive retinal input to many 
subconscious visual responses. When ipRGCs are killed, you lose circadian 
photoentrainment, the pupillary light reflex, and activity masking12,13. These results really 
solidified ipRGCs as central and critical components of the subconscious visual response 
circuitry. 
 
Neurotransmission in the retina 
 Communication by neurons in the retina is achieved through the release of 
neurotransmitters. The primary neurotransmitter in the retina is glutamate. Photoreceptors 
communicate with bipolar cells via glutamate, bipolar cells talk to RGCs via glutamate, 
and RGCs communicate with the brain with glutamate. However, the modulatory cells in 
the retina, horizontal and amacrine cells, are known to use a multitude of different 
neurotransmitters. Glycine, GABA, dopamine, and acetylcholine are just a few examples.  
 Researchers realized early on that ipRGCs were unique among RGCs in more 
than their photosensitivity. PACAP, a peptide neurotransmitter, was found to be present 
in addition to glutamatergic machinery14–16. A significant amount of work has gone into 
understanding the reason ipRGCs need two neurotransmitters, but it still remains an open 
question. The general consensus so far is that PACAP plays a minor role in supporting 
glutamatergic neurotransmission.  
6 
 
In this thesis, I have defined the roles of glutamate and PACAP in the ipRGC 
system, and I have expanded ensemble of ipRGC neurotransmitters to include 
somatostatin and substance P. 
 
The pupillary light reflex (PLR) 
 The pupillary light reflex is a critical component of the visual system. It allows 
the visual system to autoregulate the intensity of sensory input and keep it in an optimal 
range for function. The primary reason I have focused on the PLR is because of the 
incredible advantages it provides for research in vivo.   
For research purposes, the PLR has many features that make it an ideal system of 
study. First, the input is well defined – ipRGCs are the exclusive source of retinal 
information. Second, the output, pupil size, is readily observable, easily quantifiable, and 
unambiguous in interpretation. Finally, the light stimulus can be easily controlled and 
modulated so you know exactly what you are putting into the system. 
Using the PLR as an assay for ipRGC sensory function and neurotransmission 
allows us to make quantitative conclusion about the system in vivo which is critical to 
understanding ipRGCs in the context of the whole organism. 
 
Contents of this thesis 
 During my thesis work, I have focused on two primary questions regarding the 
ipRGC system. (1) the role rod, cone, and melanopsin light detection in the ipRGC 
circuit. (2) the contribution of glutamatergic and PACAPergic neurotransmission toward 
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ipRGC-elicited behavioral responses. chapter 2 is based on now published work which 
answers several aspects of both questions and forms the basis for chapters 3 and 4. These 
chapters follow up on questions that arose as a result of the experiments presented in 
chapter 2 with respect to (2). chapter 5 is a simple and straightforward method that I 
devised on a walk home from lab and I hope will be useful for neuroscience moving 
forward. chapter 5 is based on a manuscript currently in review. 
 As a note, chapters 2 and 5 are completed manuscripts and are written as such. 
Chapters 3 and 4 are not yet complete stories with satisfying answers. However, they 
highlight interesting and unstudied aspects of the ipRGC system and provide a starting 
point for future work in the field. 
 Chapter 2 lays the groundwork for all subsequent work in this thesis. I highly 







Chapter 2: Mechanisms supporting rapid 
and sustained phases of ipRGC signaling 
 
This chapter is based on a published manuscript: 
William T Keenan*, Alan C Rupp*, Rachel A Ross, Preethi Somasundaram, Suja 
Hiriyanna, Zhijian Wu, Tudor C Badea, Phyllis R Robinson, Bradford B Lowell, 
and Samer Hattar. A visual circuit uses complementary mechanisms to support 
transient and sustained pupil constriction. eLife (2016).  




Rapid and stable control of pupil size in response to light is critical for vision, but the 
neural coding mechanisms remain unclear. Here, we investigated the neural basis of pupil 
control by monitoring pupil size across time while manipulating each photoreceptor input 
or neurotransmitter output of intrinsically photosensitive retinal ganglion cells (ipRGCs), 
a critical relay in the control of pupil size. We show that transient and sustained pupil 
responses are mediated by distinct photoreceptors and neurotransmitters. Transient 
responses utilize input from rod photoreceptors and output by the classical 
neurotransmitter glutamate, but adapt within minutes. In contrast, sustained responses are 
dominated by non-conventional signaling mechanisms: melanopsin phototransduction in 
ipRGCs and output by the neuropeptide PACAP, which provide stable pupil maintenance 
across the day. These results highlight a temporal switch in the coding mechanisms of a 
neural circuit to support proper behavioral dynamics.  
 
Introduction 
Environmental light influences a variety of subconscious physiological functions, 
including circadian photoentrainment, light modulation of sleep/mood, and the pupillary 
light response (PLR). These diverse effects of light are all mediated by a small 
subpopulation of retinal output neurons called intrinsically photosensitive retinal 
ganglion cells (ipRGCs) 12,13,17–21. Even in the vast array of environmental light 
conditions, subconscious visual behaviors are remarkable for their rapid induction and 
stable maintenance throughout the day. However, how the ipRGC circuit achieves rapid 
and stable control of visual behaviors remains uncertain. 
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Multiple photoreceptive systems participate in the ipRGC circuit, including their 
endogenous melanopsin-based phototransduction and indirect synaptic input from the 
classical rod and cone photoreceptors 22,23. Each photoreceptive system presumably 
encodes a unique aspect of the light environment, but to date no consensus exists on the 
photoreceptive mechanisms supporting ipRGC-dependent behaviors. Several studies 
using a variety of methods have proposed competing models arguing for the 
predominance of cone-based 24–27 or rod-based 28,29 synaptic input to ipRGCs and their 
behavioral responses. Additionally, it has been suggested that melanopsin mediates 
persistent light detection in ipRGCs 17,20,30–32 because melanopsin phototransduction is 
relatively slow to initiate but stable for minutes to hours 31,33,34. However, animals lacking 
melanopsin still retain sustained light responses in ipRGCs and their central targets 34–36 
and relatively normal circadian photoentrainment 37,38 and PLR 39,40. In total, it remains 
unclear how ipRGCs utilize each distinct photoreceptive input, especially across the 
environmental range of light intensities and durations. 
ipRGCs must faithfully relay information about the light environment to the brain. 
Many neurons, including ipRGCs, release multiple neurotransmitters, a classical 
neurotransmitter and one or more neuropeptides 41. However, systems to evaluate 
mammalian cotransmitter systems in vivo in real time are lacking. ipRGCs contain the 
principal excitatory neurotransmitter glutamate and the neuropeptide PACAP (pituitary 
adenylyl cyclase-activating polypeptide) 14,42. Recent studies have suggested that 
glutamate is the predominant regulator of ipRGC-dependent behaviors, including 
circadian photoentrainment and the PLR 43–45. By comparison, animals lacking PACAP 
or its receptors show at best minor deficits in circadian photoentrainment and the PLR 46–
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50. This difference in outcomes between glutamate and PACAP has led to the conclusion 
that PACAP is dispensable and serves primarily as a modulator of glutamatergic 
signaling 51. It remains puzzling why ipRGCs, like many other neuronal cell types, would 
possess two distinct neurotransmitters. 
To date, the precise behavioral contributions of rod, cone, and melanopsin input 
or their output neurotransmitters glutamate and PACAP to visual behaviors across time 
are essentially unknown. Here, we have systematically addressed the behavioral 
contributions of all three photoreceptive inputs and both neurotransmitter outputs of 
ipRGCs, and how these change with time. To do so, we have silenced each individual 
photoreceptor or neurotransmitter component of ipRGCs, and in multiple combinations, 
while measuring pupil size across environmental light intensities and time domains. We 
have taken advantage of the fact that the PLR provides the unique opportunity to dissect 
the precise temporal dynamics of inputs and outputs of the ipRGC circuit in a behaving 
animal. This study reveals how ipRGC circuit dynamics in vivo support pupil regulation 




ipRGC behavioral responses are composed of both transient and sustained phases 
To measure ipRGC responses in real time, we measured the pupillary light 
response (PLR). Importantly, we used a novel experimental setup that mimics 
environmental light using overhead light with spectral composition similar to daylight in 
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an unanesthetized mouse (Figure 1A and Figure 1—figure supplement 1), unlike 
previous studies that used monochromatic light delivered to a single eye 13,25,31,39,45,47. 
Following light onset, we observed rapid pupil constriction that is maintained for 
the duration of the 30-second recording (Figure 1B), with greater constriction under 
higher light intensities (Figure 1D). Previous studies have noted a PLR decay during a 
sustained light stimulus lasting minutes 28,31,52, prompting us to systematically monitor 
the pupil across a range of times and light intensities. We observed a decay in pupil 
constriction over time that reached a new steady state (Figure 1C), resulting in two 
phases in the PLR: transient and sustained (mean intensity to reach 50% constriction 
(EC50) for transient PLR = 0.53 lux, sustained PLR = 7.9 lux)(Figure 1D,E). Because 
pupil constriction itself lowers the amount of light reaching the retina and therefore limits 
the drive to continued pupil constriction, the PLR is a form of negative feedback. To test 
if PLR decay is a consequence of negative feedback, we measured the effect of negative 
feedback both computationally and experimentally, and found that it has little role in PLR 
decay (Figure 1—figure supplement 2). Furthermore, we observed full PLR decay at 
dim light intensities (≤1 lux) within the first 5 minutes of light stimulation (Figure 1C,F), 
but full maintenance of pupil constriction at high light intensities (≥1000 lux), with 
apparently slower decay rates at higher light intensities (half-life: ~2–5 minutes, Figure 
1F). These results suggest that ipRGCs possess temporally distinct inputs and/or outputs 




Transient input to ipRGCs is mediated by rods 
To identify the photoreceptor(s) inputs that contribute to transient ipRGC 
responses (Figure 2A), we tested the PLR in mutant mouse lines that lack the function of 
a single photoreceptor type, leaving the function of the other photoreceptors intact (Table 
1, for references on production and initial characterization of each line); we refer to these 
lines as cone knockout, rod knockout, and melanopsin knockout mice. To corroborate our 
findings, we tested a variety of mutant mouse lines that silence each photoreceptor type 
in unique ways (Table 1). 
Importantly, these mutant mouse lines have been extensively tested for visual 
function 29,53–59. Rod sensitivity and function is unchanged in cone mutant animals and 
cone sensitivity and function is unchanged in rod mutant animals 29,53–58. 
Electrophysiological recordings of ipRGCs show functional rod input in cone mutants 
and functional cone input in rod mutants 59. Additionally, all of the photoreceptor mutant 
lines we used have similar pupil sizes in darkness (Figure 2—figure supplement 1). 
Therefore, these mouse lines allow precise separation of rod, cone, and melanopsin 
activation while leaving the function of the other photoreceptors intact.  
When we tested the transient PLR of rod, cone, and melanopsin mutant mice, we 
found that both cone and melanopsin knockout mice were identical to wildtype in both 
sensitivity and kinetics (Figure 2B and Figure 2—figure supplement 2B). Despite 
previous reports of melanopsin requirement for the transient PLR 39, we find that 
melanopsin is dispensable for the PLR when using more environmentally relevant stimuli 
(Figure 2—figure supplement 3). In contrast, rod knockout mice displayed no pupil 
constriction until the light intensity becomes relatively bright (i.e. >10 lux, Figure 2B), 
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despite the normal spatial vision in rod knockout mice at these moderate light intensities 
53. To corroborate these results, we tested three different cone mutant lines and two 
different rod mutant lines with distinct mutations and observed virtually identical results: 
cone mutants are similar to wildtype and rod mutants have severe transient sensitivity 
deficits (Figure 2—figure supplement 2C,D).  
These results are surprising given previous proposals that cones are important for 
transient ipRGC responses, including acute changes in pupil size 24–26,31,60–65. Therefore, 
we sought to acutely modulate cone activity using a previously characterized mouse line 
that expresses the human ‘red’ opsin (OPN1LW) in place of the mouse ‘green’ opsin 
(Opn1mw) (Red cone KI), making cones the only photoreceptors with enhanced 
sensitivity to red light 25 (Figure 2C). We found that these mice have identical transient 
PLR in response to red light as wildtype (Figure 2D), indicating that acute cone 
modulation does not affect the overall magnitude of the PLR. Furthermore, crossing this 
line to a rod knockout line abolishes the PLR in response to red light (Figure 2E). These 
results show that rods are the predominant photoreceptor inputs for transient PLR at low 
to moderate light intensities, even in a mouse line with sensitized cones. 
 To evaluate the inputs contributed by each photoreceptor in isolation to the PLR, 
we generated double mutants lacking the function of two photoreceptor types, resulting in 
mice with only rods (Rods alone), only cones (Cones alone) or only melanopsin 
(Melanopsin alone) (Table 1). We found that the only photoreceptors capable of 
recapitulating the wildtype PLR are rods. Mice with only rod function had identical light 
sensitivity as wildtype and a similar rapid induction of pupil constriction (Figure 2F,G), 
though their ability to maintain stable pupil sizes in bright light was slightly diminished 
15 
 
(Figure 2G). We corroborated the sufficiency of rods using three different mouse lines 
(Figure 2—figure supplement 4). Interestingly, while two of the lines were nearly 
identical to wildtype, one line had similar sensitivity, but altered kinetics, suggesting that 
cones might regulate rod signaling dynamics. 
In marked contrast to rod input, cone and melanopsin inputs were severely 
deficient in mediating the transient PLR (Figure 2F,G). Animals with melanopsin alone 
retained a normal PLR at bright light intensities (Figure 2F), as seen previously 31,40,66, 
with sensitivity that is indistinguishable from rod knockouts (Figure 2—figure 
supplement 5), though they had relatively sluggish kinetics (Figure 2G). In contrast, 
cone-only animals had minimal PLR (Figure 2F), resulting in a further sensitivity deficit 
compared to rod knockout and melanopsin-only animals (Figure 2—figure supplement 
5). Additionally, cone input decayed rapidly (Figure 2G), presumably due their robust 
light adaptation properties. 
 Collectively, these results show that rods serve as the primary input to ipRGCs for 
transient PLR responses, especially at low to moderate light intensities. At bright light 
intensities, additional input originates predominantly from melanopsin phototransduction. 
 
Glutamaterigic output provides precise and rapid transient signaling 
To investigate how ipRGCs relay transient light detection to the brain, we tested 
the transient PLR in mice lacking glutamatergic neurotransmission in ipRGCs (Opn4Cre/+; 
Slc17a6fl/fl, also known as Vglut2fl/fl) or mice lacking PACAP in ipRGCs (Opn4Cre/+; 
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Adcyap1fl/-) (Figure 3A and Table 2). See Figure 3—figure supplement 2 for details on 
design of the conditional PACAP allele (Adcyap1fl).  
 Though ipRGC glutamate knockout mice (Opn4Cre/+; Slc17a6fl/fl) exhibited a 
small decrease in resting pupil size (Figure 3—figure supplement 1) 45, we observed 
that they had minimal transient PLR at all light intensities (Figure 3B-E), with more 
robust PLR at very bright light intensities (Figure 3—figure supplement 3), in 
agreement with previous studies 44,45. This indicates that ipRGC glutamatergic 
neurotransmission is a critical transient signal for the PLR. Presumably, the residual 
transient response is PACAPergic.  
In contrast to ipRGC glutamate knockout mice, ipRGC PACAP knockout mice 
had no deficits in transient PLR sensitivity or kinetics (Figure 3B-E), as observed 
previously 47, suggesting that glutamate is sufficient for the entirety of the transient PLR. 
Additionally, these results show that any potential modulation of glutamatergic signaling 
by PACAP 51,67 is dispensable for the transient PLR. Together, these data derived from 
retinal mutants for photoreceptors and neurotransmitters identify rods as the principal 
input and glutamate as the principal output of ipRGC-mediated transient PLR signaling.  
 
Melanopsin/rod synergy supports PLR under sustained conditions 
Since wildtype responses decay over time (Figure 1), we next asked how ipRGC 
inputs and outputs drive the PLR across longer times (Figure 4A). Strikingly, when we 
measured the sustained PLR in melanopsin knockout mice, which have a normal transient 
PLR (Figure 2B), there was virtually no pupil constriction (Figure 4B), even at bright 
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light intensities (up to 10,000 lux, Figure 4—figure supplement 1A). We observed that 
melanopsin knockout mice lose pupil constriction in minutes (half-life: ~4 minutes, 
Figure 4C), similar to the wildtype PLR decay rate at lower light intensities (WT half-
life range: ~2–4 minutes at 1–100 lux, Fig. 1F). This suggests that melanopsin 
phototransduction maintains robust light input in ipRGCs during the day (Figure 4—
figure supplement 1B), after rods adapt to background light.  
The severe deficits we observed in the sustained PLR in melanopsin knockout 
mice raised the possibility that these animals may have developmental deficits that affect 
their signaling 68,69. To directly address this issue, we rescued ipRGC function in adult 
melanopsin knockout mice using either chemogenetics or restoration of melanopsin 
expression. Using our mouse line with Cre introduced into the melanopsin locus 
(Opn4Cre/Cre) and a Cre-dependent chemogenetic DREADD virus (AAV2-hSyn-DIO-
hM3D(Gq)-mCherry) (Figure 4—figure supplement 2), we administered the selective 
DREADD agonist CNO 70 and observed robust and sustained pupil constriction for at 
least one hour (Figure 4D). This result demonstrates that ipRGCs and their downstream 
circuits remain competent for sustained signaling in melanopsin knockout mice. 
Furthermore, we acutely restored melanopsin in the majority of ipRGCs of melanopsin-
Cre knockout mice (Opn4Cre/Cre) using a virus that expresses melanopsin in a Cre-
dependent manner (Figure 4E and Figure 4—figure supplement 2C-E, AAV2-CMV-
DIO-mRuby-P2A-Melanopsin-FLAG). Following melanopsin restoration, we observed a 
rescue of the sustained PLR (Figure 4F). These results demonstrate for the first time that 
the effect of melanopsin loss can be rescued in adulthood, indicating that melanopsin-
based light detection is directly required for ipRGCs to signal sustained PLR. 
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Surprisingly, although melanopsin is required for sustained signaling, we found 
that melanopsin signaling could not fully recapitulate the sustained PLR. Despite the 
observation that the sustained PLR is normal at bright light intensities in melanopsin-only 
mice, these mice had a sensitivity deficit compared to wildtype (Figure 4G). Notably, we 
observed that rod knockout mice display an identical sensitivity deficit as melanopsin-
only (Figure 4G and Figure 4—figure supplement 3), indicating that rods contribute to 
sustained ipRGC signaling. This indicates that at intermediate intensities, both rod and 
melanopsin signaling cooperate to sustain the PLR.  
As with the transient PLR, we found that cone knockout mice had no deficit in 
sustained PLR (Figure 4G). Again, multiple independent mouse lines corroborate these 
conclusions (Figure 4—figure supplement 3). Furthermore, we found that rods alone 
could drive the remainder of the sustained PLR in melanopsin knockout mice (Figure 
4—figure supplement 4A), whereas cone-only mice had no sustained PLR (Figure 4—
figure supplement 4B).  
These results show that melanopsin signaling dominates sustained light input to 
ipRGCs, but rods, which are thought to be nonfunctional under continuous bright light, 
are intimately involved in supporting the sustained PLR. Notably, rod contributions to the 
sustained PLR occur predominantly at light intensities above their presumed saturation 
(~40 lux), showing that rods are indeed capable of contributing to visual function above 
previously defined limits 29,53,57. Therefore, sustained ipRGC responses are not a simple 
consequence of a single photoreceptive system, but instead require rod/melanopsin 




PACAP is essential for the sustained PLR 
Studies of ipRGC neurotransmitters, in combination with our transient PLR 
results presented here, suggest that glutamate is the primary ipRGC neurotransmitter, and 
that PACAP plays a minor, or modulatory, role 44,45,47–50,71. However, when we tested the 
sustained PLR in ipRGC glutamate knockout mice, we found that their pupil constriction 
improved over time compared to their transient PLR sensitivity (Figure 5B,C). In 
contrast, PLR sensitivity either stays the same or declines in all other mutant lines, 
suggesting that the remaining signal in glutamate knockout mice, presumably PACAP, 
becomes more effective with longer stimulus duration. Intriguingly, ipRGC glutamate 
knockout mice showed pulsatile or periodic pupil constriction over time, potentially due 
to waves of neuropeptide vesicle delivery and release from ipRGC axons (Video 1). 
Neuropeptides have been shown to require high frequency neuronal activity for 
release and have relatively slow signaling kinetics compared to classical 
neurotransmitters 41, suggesting that PACAP may be involved in sustained ipRGC 
signaling at bright light intensities. In support of a role for PACAP in sustained PLR 
signaling, we find that even though ipRGC PACAP knockout mice show normal transient 
PLR, they have an attenuated sustained PLR (Figure 5B-E). This deficit in ipRGC 
PACAP knockout mice occurs even at moderate light intensities (10 and 100 lux). ipRGC 
PACAP KO mice display decaying constriction over time at 1000 lux as opposed to 
maintained constriction in wildtype mice and enhanced constriction in ipRGC glutamate 
KOs (Figure 5D). At the brightest light intensity tested, 5000 lux, ipRGC PACAP KO 
mice display present significantly worse sustained constriction than ipRGC glutamate KO 
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mice (Figure 5E), suggesting that PACAP is more important than glutamate for 
maintained responses under daylight conditions (1,000-100,000+ lux).  
Additionally, we observed similar yet more pronounced deficits in full body 
PACAP KO mice (Adcyap1-/- ; Figure 5—figure supplement 1). They display wildtype 
transient responses (Figure 5—figure supplement 1A,B) and severely attenuated 
sustained responses (Figure 5—figure supplement 1C-E). Interestingly, these PACAP 
knockout mice exhibit PLR decay on a similar timescale as melanopsin knockout mice 
(half-life: ~5 minutes, Figure 4C and Figure 5—figure supplement 1F). These results 
provide evidence that PACAP allows ipRGCs to communicate sustained input to 
downstream neurons. As observed with the photoreceptor contributions, the highest 
sensitivity of sustained PLR requires PACAP/glutamate synergy. 
 
Model of ipRGC circuit transitions 
 Based on our results, we generated a quantitative representation of the distinct 
roles played by each photoreceptor input and neurotransmitter output of ipRGCs for the 
PLR over a range of light intensities and light stimulus durations (Figure 6, see Methods 
for detailed explanation). We integrated individual necessity (i.e. from knockout lines) 
and sufficiency (i.e. from ‘–only’ lines) of rods, cones, and melanopsin in driving the 
PLR (Figure 6—figure supplement 1) to generate a merged heat map representing each 
photoreceptor’s input to the PLR (Figure 6A,B). We then performed the same technique 
to represent the neurotransmitter outputs of ipRGCs for the PLR (Figure 6C,D and 
Figure 6—figure supplement 1) using only the necessity heat maps because we cannot 
rule out the possibility that other neurotransmitters contribute to ipRGC function. These 
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heat maps provide a comprehensive visualization of the contribution made by each 
photoreceptor’s input and each neurotransmitter’s output for ipRGC signaling at any 
particular time or environmental light intensity. ipRGC transient signaling for the PLR is 
dominated by input from rods (Figure 6A, red) and output by glutamate (Figure 6C, 
green). In contrast, sustained PLR signaling is dominated by melanopsin (Figure 6B, 
blue) and PACAP (Figure 6D, blue). Together, these experiments and our model 




 We show here how inputs and outputs for a specific circuit change across time to 
support a behavioral response. Remarkably, the mechanisms supporting transient and 
sustained responses are distinct, suggesting stimulus duration as a critical determinant of 
circuit state. Transient PLR responses predominantly utilize classical, well-characterized 
visual system synaptic mechanisms: rod phototransduction and signal relay to ipRGCs, 
followed by ipRGC glutamatergic output. However, as conventional signaling 
mechanisms adapt, non-conventional mechanisms are recruited to maintain persistent 
signaling, including endogenous melanopsin phototransduction and peptidergic 
neurotransmission through PACAP. Our findings highlight fundamental circuit changes 
in the light-adapted retina that are relatively unexplored 72. 
Our results reveal the roles of distinct photoreceptors and neurotransmitters in the 
PLR and probably other ipRGC-dependent behaviors. We show how ipRGC inputs and 
outputs can contribute to the PLR through changes in their relative contribution across 
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stimulus intensity and duration. Our ability to decipher these elaborate dynamic changes 
stems from the fact that we used a large array of environmental light intensities and 
durations, coupled with genetic means to silence individual circuit components. 
Ultimately, our quantitative model makes testable predictions about the role of each 
photoreceptor and neurotransmitter for other ipRGC-dependent behaviors. 
We show that in contrast to many proposed models, rods provide the exclusive 
transient input to ipRGCs for the PLR at dim (scotopic) and moderate (mesopic) light 
intensities. That rods are capable of rapid and sensitive input to ipRGCs is not surprising 
given electrophysiological evidence of sensitive rod input to ipRGCs 59,73 and the fact 
that rods are widely appreciated as the mediators of dim light vision. However, their 
exclusive input at mesopic light intensities suggests that cone input to ipRGCs is 
relatively weak, consistent with the inability of cones to drive circadian photoentrainment 
25,74. Furthermore, we report here that in addition to their role in high-sensitivity transient 
signaling, rods are capable of driving sustained signaling at bright light intensities well 
above their saturation level (~40 lux, Figure 4—figure supplement 4). This agrees with 
previous findings that rods are capable of supporting circadian photoentrainment at bright 
light intensities 29 but also provides more precise temporal kinetics of rod input to 
subconscious behaviors. It has been proposed that rods never fully saturate 75, and here 
we provide a physiological role for rod activity at daylight intensities.  
In contrast to previous data that melanopsin is largely dispensable for the PLR 39, 
we find that it is the dominant determinant of pupil size during the day. This is likely due 
to the fact that rod and cone inputs adapt to background light, while we find no evidence 
of behavioral light adaptation in melanopsin phototransduction (i.e. identical sensitivity 
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of melanopsin-only mice in transient and sustained PLR). While melanopsin 
phototransduction adapts in vitro 76,77, it has been proposed that only the adapted state is 
able to influence downstream behaviors 77. We predict that melanopsin will be required in 
other visual functions throughout the day, for example as in more natural 
photoentrainment conditions that need to precisely measure changing light intensity 
under bright conditions or measuring day length 32,65,78. This requirement for melanopsin 
in sustained light detection is likely the main reason melanopsin has been conserved in 
vertebrates.   
To date, glutamatergic neurotransmission is the only retina-brain signaling 
mechanism that has been robustly characterized. We confirm previous data that ipRGCs 
predominantly rely on glutamatergic output for the transient PLR 43–45. However, we 
show that the stimulus durations in which glutamate predominates over PACAP is 
relatively restricted (<5 min), revealing the first critical role for a neuropeptide in retinal 
signaling to the brain. Further, we find that PACAP appears sufficient to drive the PLR 
independent of its potential to modulate glutamate. There have been discrepancies in the 
literature about the role of PACAP in the PLR 46,47, which we believe is likely due to 
differences in light stimulus duration. Intriguingly, PACAPergic neurotransmission 
appears to be pulsatile, potentially reflecting the imprecision of slow vesicle delivery 
from the soma and suggesting why ipRGCs also require a fast and reliable glutamatergic 
signal. Glutamate and PACAP are the only known ipRGC neurotransmitters, but it 
remains possible there are neurotransmitters which remain undiscovered. An ipRGC-
specific glutamate/PACAP double knockout is a crucial next step in understanding 
ipRGC neurotransmission. Given the expression of other neuropeptides in many RGCs, 
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including ipRGCs 79–82, it remains possible that neuropeptides have a broader role in 
visual function than previously appreciated.  
The complementary arrangement of inputs and outputs for the PLR we describe 
here demonstrates how the visual system accomplishes high sensitivity, transient 
responses as well as integrative, long-term responses. Many other signaling systems may 
employ discrete methods for signaling robustly through time. While melanopsin is 
specific to the ipRGC circuit, PACAP and other neuropeptides may play similar roles in 
long-term signaling in other circuits, such as hypothalamic feeding circuits 83. Expanding 
the timescales over which we investigate these systems is likely to reveal entirely new 
aspects of cell signaling. 
 
Materials and Methods 
Animal husbandry 
C57Bl/6 × Sv129 hybrid mice were used in all experiments except PACAP KO 
mice which were C57Bl/6. All mice were housed according to guidelines from the 
Animal Care and Use Committee of Johns Hopkins University. Male and female mice 
age 2–8 months were housed in plastic translucent cages with steel-lined lids in an open 
room. Ambient room temperature and humidity were monitored daily and tightly 
controlled. Food and water were available ad libitum. All mice were maintained in a 






All mice were dark-adapted for at least 30 minutes prior to any experiments and 
all PLR experiments were performed between Zeitgeber times (ZT) 2 and 10. For all 
experiments, mice were unanesthetized and restrained by hand. Because stress can affect 
pupil size, we ensured that the mice were not stressed during these experiments. To do so, 
we handled the mice for several days prior to the experiments to get them accustomed to 
the researchers and to being scruffed. Any mice that showed signs of stress, including 
vocalizations and wriggling during the experiments, were not used and were subjected to 
more handling sessions before use in experiments.  
Mice were restrained manually under a 10-, 13-, or 23-Watt compact fluorescent 
light bulb (GE Daylight FLE10HT3/2/D or Sylvania Daylight CF13EL and CF23EL) 
with a color temperature of 6500 K to simulate natural sunlight. The light intensity was 
measured using a light meter (EXTECH Foot Candle/Lux Light Meter, 401025) at the 
surface on which the mouse was held. The light meter was initially calibrated by 
EXTECH using a Tungsten 2856 K light source; because our experiments used a 
fluorescent bulb of 6500 K, all measured light intensities reported here may vary by 
0.92–1.12 times the actual light intensity. Light intensity was adjusted by a combination 
of altering the distance of the light bulb(s) from the mouse and/or applying neutral 
density filters (Roscolux). The light meter is incapable of detecting light intensities below 
1 lux, so one neutral density filter cutting the light intensity by 12.5% was applied to the 
bulb to estimate 1-log unit decreases in illumination below 1 lux. Light intensities above 
500 lux required the use of multiple light bulbs. 
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For the monochromatic light PLR experiments, an LED light (SuperBrightLEDs) 
was housed in a microscope light source with fiber optic gooseneck arms to direct the 
light source to the mouse eye. For the experiments involving the Opn1mwred mice, we 
used a 626-nm LED in this setup and directed light to both eyes simultaneously or to just 
one eye and measured the PLR in the illuminated eye (see figure legends). The photon 
flux was measured using a luminometer (SolarLight) and converted from W/m2 to 
photons/cm2/sec. The light intensity was decreased by 12.5% using neutral density filters 
(Rosco).  
Videos of the eye were taken using a Sony Handycam (DCR-HC96) mounted on 
a tripod a fixed distance from the mouse. Manual focus was maintained on the camera to 
ensure that only one focal plane existed for each mouse and that therefore variable 
distance from the camera should not contribute to differences in relative pupil area 
throughout the video. Pupil size was first recorded under dim red light and the 
endogenous infrared light source of the camera to capture the dark-adapted pupil size. 
Following at least 5 seconds of recording in dark, the pupil was continuously recorded for 
at least 30 seconds of a light step stimulus. For all sustained PLR, animals were kept in a 
cage for 60 minutes under the light stimulus. Animals were removed from the cage after 
60 minutes and held in front of the camera for 30 seconds as for the transient PLR. All 
pupil images presented in the paper were cropped to a fixed square area (generally 100 × 
100 pixels) surrounding the eye using GNU Image Manipulation Program (GIMP). The 
images were made grayscale and then brightness and contrast were adjusted to enhance 




Data analysis  
Videos were transferred from the camera to a computer as Audio Video Interleave 
(AVI) files and individual frames were taken using VLC media player 
(www.videolan.org/vlc/) and saved in portable network graphics format (PNG). Images 
were taken in the dark, at 5 seconds, and 30 seconds following stimulus onset. Pupil area 
was then quantified manually in ImageJ (http://rsbweb.nih.gov/ij/) software. The pupil 
area was measured in pixels using the oval tool in which the 4 cardinal points of the oval 
were touching their respective edges of the pupil. The relative pupil area was calculated 
using LibreOffice Calc or Microsoft Excel in which the area during the light stimulus was 
divided by the area prior to lights onset. For the transient PLR, the minimum relative 
pupil size of either 5 seconds or 30 seconds after stimulus was used for all genotypes. 
The intensity-response curve was fit using a variable slope sigmoidal dose-
response curve in Graphpad Prism 6. The top and bottom of the fit were constrained to 
1.0 and between 0 and 0.10, respectively, to ensure the EC50 for each genotype was 
represented by similar curves. For genotypes that never showed evidence of reaching 
between 0 and 0.10 relative pupil size, the bottom was not constrained. The sensitivity for 
each genotype was calculated using the same process of fitting each individual animal’s 
data points with a sigmoidal dose-response curve to generate EC50. 
 
Conditional PACAP allele 
  The lox-modified PACAP (Adcyap1) targeting construct was made by 
recombineering technology. To engineer the targeting vector, 5’ homology arm, 3’ 
homology arm and CKO region were amplified from mouse Sv129 BAC genomic DNA 
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and confirmed by end sequencing (Cyagen biosciences, Santa Clara, CA). The two loxP 
sites flank the second exon and when recombined, create a frameshift mutation and 
truncated protein. The plasmid was electroporated into W4 ES cells and cells expanded 
from targeted ES clones were injected into C57BL6 blastocysts. Germline transmitting 
chimeric animals were obtained and then mated with flpE mice to delete the frt-site 
flanked neomycin selection cassette. The resulting heterozygous offspring were crossed 
to generate homozygous PACAPlox/lox study subjects. All mice are thus on a mixed 
C57Bl6/J and 129Sv background. Offspring were genotyped by PCR using 2 primers (F: 
CCGATTGATTGACTACAGGCTCC and R: GTGTTAAACACCAGTTAGCCACGC) 
which detect the presence or absence of the 5’ loxP site and a 3rd primer was used in 
conjunction with the forward primer (CKO-R GGGCTTTGATCTGGGAACTGAAG) to 
detect the recombination event. By generating mice homozygous for a germline deleted 
cre-deleted allele, we have established that the cre-deleted allele does not express intact 
PACAP mRNA (by PCR and by ISH). A more detailed description of the generation and 




Mice were anesthetized by intraperitoneal injection of avertin (2, 2, 2-
Tribromoethanol) and placed under a stereo microscope. 1 μl of AAV2-hSyn-DIO-
hM3DGq-mCherry (4.6 × 10
12 viral particles/ml, Roth lab, UNC Vector Core) or AAV2-
CMV-DIO-mRuby-P2A-Melanopsin-FLAG (Robinson lab, UMBC) was placed on a 
piece of Parafilm and drawn into a 10-μl microcapillary tube (Sigma P0674) that had 
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been pulled to a needle (Sutter Instruments, Model P-2000). The loaded needle was then 
placed in the holster of a pico-injector (Harvard Apparatus PLI-90). The needle 
punctured the eye posterior to the ora serrata and air pressure was used to drive the viral 
solution into the vitreous chamber of the eye to ensure delivery specifically to the retina. 
Mice recovered from surgery on a heating pad until they woke from anesthesia. All PLR 
experiments and confocal imaging were done at least 3 weeks following viral injection. 
 
Immunofluorescence and confocal microscopy 
Mice that had been infected with the AAVs were anesthetized with avertin and 
then euthanized using cervical dislocation. The eyes were removed and the retinas were 
dissected in PBS and then fixed in 4% paraformaldehyde for 1–2 hours on ice. The 
retinas were then washed in PBS at least three times before mounting on a microscope 
slide (Fisher) in Fluoromount (Sigma) with DAPI (2-(4-amidinophenyl)-1H -indole-6-
carboxamidine). Some retinas were co-stained for melanopsin using rabbit anti-OPN4 
(Advanced Targeting Systems, AB-N38, 1:1000) in 4% goat serum with secondary 
antibody Alexa Fluor 488 goat anti-rabbit (Life Technologies A11008, 1:1000). Images 
were taken on a Zeiss LSM 710 confocal microscope using a 20× objective. After 
imaging, images were made grayscale, background subtracted, and brightness and 
contrast were adjusted in FIJI (http://fiji.sc) for the image presented in the paper. 
 
Statistical analysis 
All statistical tests were performed in Graphpad Prism 6. Specific statistical 
comparisons are listed in the figure captions. Because the EC50 data appears to be a 
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normal distribution on a log scale (log-normal distribution), all statistical tests and data 
analysis involving EC50 were performed on the log transformed data set.  
 
Heat map generation 
The photoreceptor contribution heat map was generated by first creating estimated 
pupil size matrices for the both the rapid and sustained PLR at every light intensity and 
time for wildtype mice (x axis = time, y axis = intensity). To do so, we applied the 
equation for a one-phase association: 
(1) 𝑌 = 𝑌0 + (𝑃𝑙𝑎𝑡𝑎𝑒𝑢 − 𝑌0) ∗ (1 − 𝑒(−𝐾∗𝑥)) 
In our case, Y is the relative pupil area generated at time, x. For the WT rapid PLR heat 
map, Y0rapid is set to 1 for every light intensity and the Krapid was extracted from the 
wildtype rapid constriction kinetics curve at 100 lux. The Plateaurapid value at each light 
intensity is the rapid PLR value extracted from the WT rapid intensity-response curve fit. 
This allows us to generate a full matrix of WT pupil sizes at every intensity and time by 
knowing the final pupil size (Plateau) and the rate of constriction (K). This then generates 
a full matrix of values for every time and intensity for WT mice. 
The same method was applied to make the sustained PLR heat map. However, in 
this case, Y0sustained was set to the value of the rapid PLR at each light intensity (e.g. the 
same value as Plateaurapid). The Plateausustained value is extracted from the sustained 
intensity-response curve fit at each intensity.  The Ksustained was extracted from our 
wildtype sustained time courses (Fig. 1c). Because the decay rate for sustained 
constriction appeared to change with intensity (Fig. 1f) we used a sigmoidal curve fit to 
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our experimentally determined decay rates (1, 10, 100 lux) to generate decay rates for a 
range of light intensities. We constrained the top and bottom of this curve to the decay 
rates determined for 1 and 100 lux respectively.  
This process was used to generate two matrices of relative pupil areas with the y-
axis being light intensity varying logarithmically (0.001-100,000 lux) and the x-axis 
being time varying linearly from 0 to 30 seconds for the rapid and 30 seconds to 60 
minutes for the sustained. This was done using a custom MATLAB script.  
The matrices generated for the wildtype mice were also done to the photoreceptor 
mutants. In order to determine necessity of a photoreceptor we subtracted rod (average of 
Gnat1-/- and Rod-DTA), cone (average of Cnga3-/-, Gnat2-/- and Cone-DTA), or 
melanopsin (Opn4-/-) knockout matrices from the wildtype matrix. This yields larger 
values for genotypes that are more required and also normalizes for the overall 
constriction in wildtype mice at that intensity (i.e. because rods are fully necessary at 
some dim intensities at which WT mice have minimal constriction, the necessity value 
attributed to rods is small despite their absolute necessity at that intensity). To determine 
sufficiency we used ‘rod-only’ (Cnga3-/-; Opn4-/-), ‘cone-only’ (Gnat1-/-;Opn4-/-) and 
‘melanopsin-only’ (average of Gnat1-/-;Gnat2-/-, Gnat1-/-; Cnga3-/- and Rod-DTA;Cone-
DTA) matrices. Additionally, we applied the decay rate of pupil constriction from the 
‘cone-only’ mouse line transient PLR at 100 lux for all light intensities.  





Negative feedback modeling 
 In order to isolate negative feedback’s impact on the PLR, we generated a 
computational model. Computational modeling was performed with MATLAB using two 
experimentally determined parameters. First, the relative pupil area (RPA) values for the 
wildtype intensity-response curve (Fig. 1d).  These values give us the response driven 
when the pupil starts fully open.  We will later multiply the environmental intensity by 
the new relative pupil area to determine the new retinal intensity. We will use this new 
retinal intensity to extract the pupil size from the rapid intensity-response curve to find 
the constriction driven by that new intensity under baseline conditions.  The model does 
this recalculation of retinal intensity and the PLR driven by it every second for 956 
seconds.   
The second experiment integrated into the model is a 1s light pulse-chase 
experiment. Here, we dark-adapted the mouse, gave a single second of light and then 
followed subsequent constriction for 30 sec. These constriction values were normalized 
to the maximum constriction achieved, in this case the 6-sec time point. This gives us the 
ability to weight the contribution of light at a particular time to constriction at subsequent 
times. As you can see, light does not instantly constrict the pupil. It takes several seconds 
for the signal to maximally impact pupil size, which is then followed by signal decay. 
Importantly, this temporal weighting, while not required for the model, does give us a 
rough estimate of the potential kinetics of feedback’s impact on PLR decay. 
With these pieces of experimental data in hand, the model does the following at 
every light intensity (0.0001-100,000 lux): (1) it extracts the RPA in response to a 
particular light intensity from the wildtype intensity-response curve. (2) The model uses 
33 
 
the temporal weighting values from the pulse-chase experiment to weight that RPA 
across subsequent times (0-30s). This gives us a 30-sec constriction time course for the 
light detected at time zero. (3) The model next moves to time 1 sec. Now it takes into 
account the maximum constriction caused by light at previous times (time 0 in this case). 
The model uses that constriction to reduce the light intensity and calculate a new retinal 
light intensity: RPA * Light intensity = Retinal intensity. (4) Next, it determines the RPA 
driven by this new retinal intensity using the DRC once again. (5) Repeats step (2) for 
this RPA giving another time course of constriction (1-31s). (6) The model repeats steps 
(3-5) moving up in 1s increments each time. Importantly, at each new time point it finds 
the maximum constriction value in response to all previous time points in order to 
calculate the new retinal intensity. (7) Finally, it finds the maximum constriction at each 
time point in order to produce a negative feedback PLR decay time course. See graphical 
representation of the negative feedback model (Figure 1—figure supplement 2A)  
 *The primary assumption the model makes is that the PLR system has zero 
summation of signal. This is probably unlikely. However, this assumption was made to 
maximize the impact of feedback on pupil constriction. This model provides us with an 
upper bound on negative feedback’s contribution to PLR decay. 





Mathematical description of the negative-feedback model of PLR decay 
At a given environmental light intensity: 𝒍𝒖𝒙𝒐. The effect of pupillary negative-
feedback during a 956s stimulation is modeled as follows: 
𝒇𝒐𝒓 𝑡𝑖𝑚𝑒 𝒕 = 1, 2, 3…956 
𝑚𝑎𝑥 (𝑅𝑃𝐴⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  (: , 𝑡)) × 𝑙𝑢𝑥𝑜 = 𝑙𝑢𝑥𝑡               (1) 
 
 In equation (1) above, we determine the retinal light intensity, 𝒍𝒖𝒙𝒕 , that is, the 
intensity of light after modulation by pupil size at time t. At t = 1 there is no pupil 
constriction and therefore no light intensity modulation (𝑙𝑢𝑥𝑜 = 𝑙𝑢𝑥𝑡). 𝑹𝑷𝑨⃗⃗⃗⃗ ⃗⃗ ⃗⃗  ⃗ is a 956×956 
matrix which stores subsequent pupil constriction values. With 𝑙𝑢𝑥𝑡 we determine the 
constriction driven by light sensed at time, t : 
𝛼 (𝑙𝑢𝑥𝑡) × ?⃗? = 𝑅𝑃𝐴⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  (𝑡, 𝑡: 𝑡
+ 30)                (2) 
 
In equation (2), we calculate the amount of constriction driven by 𝑙𝑢𝑥𝑡 , ?⃗⃗? (𝒍𝒖𝒙𝒕) , 
and approximate the temporal characteristics of that constriction with ?⃗⃗⃗? . ?⃗⃗⃗?  is based on a 
1s light pulse-chase experiment where we followed the constriction driven by 1s of light 
for 30s. Again, we store calculated constriction values: 𝑹𝑷𝑨⃗⃗⃗⃗ ⃗⃗ ⃗⃗  ⃗(𝒕, 𝒕: 𝒕 + 𝟑𝟎). Finally, we 
extract the highest constriction value at t : 
 
𝑚𝑎𝑥 (𝑅𝑃𝐴⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  (: , 𝑡)) = 𝑀𝑜𝑑𝑒𝑙⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  ⃗
⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  ⃗
𝑙𝑢𝑥𝑜




After completing t = 956, 𝑴𝒐𝒅𝒆𝒍⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  𝒍𝒖𝒙𝒐  is a vector containing the model-predicted 
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Figure 1: The pupillary light response contains two phases: transient and sustained. 
(A) Approximate light intensity ranges (lux) at different times of day. (B) Transient 
constriction in response to a 10 lux overhead stimulus (mean ± SD). Boxes contain 
representative pupil images at time 0 and 30 seconds. (C) Continued monitoring of pupil 
constriction from b for 60 minutes of continuous light at 5 minute intervals with 
representative images. (D) Intensity-response curve for transient and sustained 
constriction (30 sec and 60 min, respectively). Data fit with a sigmoidal curve (n = 5, 
mean ± SD). (E) Light intensity required for half-maximal constriction (EC50) determined 
for both transient and sustained phases of the PLR. EC50 extracted from the sigmoidal 
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curve fits for each mouse (points are individual mice, line is mean). Statistical 
significance determined with a student’s t test. (F) Half-life of PLR decay at 1, 10, and 
100 lux. Statistical significance determined by main effect of light intensity from one-






Figure 1—figure supplement 1: Experimental setup and light stimulus details.  
(A) Environmental light intensity measured in lux across one day (April 2, 2015) in 
Baltimore, Maryland, USA. The light meter used is unable to measure light intensities 
below 1 lux, indicated with the gray box. Dotted lines refer to the meteorological sunrise 
and sunset. Data is fit with a hand-drawn curve for ease of visualization. (B) Mice are 
unanesthetized and restrained by hand under a light bulb with a broad spectrum similar to 
sunlight (C). Spectral power is normalized to the most highly represented wavelength in 
sunlight. Breaking down the fraction of light into 50 nm bins for each light source, the 
daylight bulbs are very similar to sunlight across all wavelengths (D), while incandescent 
40 
 
bulbs lack short wavelengths and are enriched in long wavelengths. Pupils are 





Figure 1—figure supplement 2: Negative-feedback model of PLR decay. 
 (A) Diagram displaying how the negative feedback model works (7s light in example) 
(See Online Methods for step-by-step explanation). The model assumes that packets of 
light information are discrete and are relayed to the PLR circuit to result in pupil 
constriction at later timepoints. We determined the kinetics of light information relay 
using  a  1-second light pulse-chase. Then, we simply modulate the relative light intensity 
reaching the retina based on assuming continuous 1-second packets of information. At 
each new 1-second interval, the model samples the assumed pupil sizes currently driven 
by each previous packet of light information, uses the maximum value as the current 
pupil size, and then reduces the stimulus intensity using that pupil size. We then use this 
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new intensity to determine constriction caused at that time. This iterates every second. 
(B) Putative kinetics of feedback’s impact on PLR at several light intensities (0.0001, 
0.001, 0.01, 0.1, 1, 10, 100, 1000, and 10,000 lux). (C) Magnitude of PLR decay caused 
by feedback as modeled with (D) EC50. Note that our model predicts minor PLR decay as 
a result of PLR feedback. (E) Experimental investigation of feedback’s role in PLR 
decay. Atropine was applied to the left eye to inhibit pupil constriction and thus feedback. 







Figure 2: Transient input to ipRGCs is mediated by rods.  
(A) Diagram of ipRGC behavioral circuit. (B) Intensity-response curves of the PLR in 
each of the photoreceptor mutant mouse lines (mean ± SD): wildtype (n = 6), Rod KO 
(Gnat1-/-  n = 6), Melanopsin KO (Opn4-/- n = 8), and Cone KO (Gnat2-/- n = 7). 
Representative pupil images for each mouse line at 10 lux. (C) Gene schematic 
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comparison of endogenous mouse M-cone allele and human red cone knock-in allele as 
well as the spectral sensitivity shift observed. Notice that cones are more sensitive to red 
light in Red cone KI line. (D) The PLR to red light (626-nm LED) is identical in mice 
with cones that are more sensitive to red light (Red cone KI, n = 6) compared to 
littermate WT (n = 5), mean ± SD. (E) Removing rod function abolishes the PLR in 
response to red light (626-nm LED), even in mice with cones with enhanced sensitivity to 
red light. WT n = 7, Red cone KI (Opn1mwred) n = 8, Rod KO (Gnat1-/-)- n = 8, Red cone 
KI; Rod KO (Gnat1-/-; Opn1mwred) n = 4. Light intensity is 14.3 log photons/cm2/s. (F) 
Intensity-response curves in mutant mice with each photoreceptor isolated (Rod-only: 
Cnga3-/-; Opn4-/- n = 6)(Cone-only: (Gnat1-/-; Opn4-/- n = 6)(Mel.-only: Gnat1-/-; Gnat2-/- 
n = 7) Data is mean ± SD, statistical significance determined using a one-way ANOVA 
with Sidak’s post-test. (right) Representative pupil images at 100 lux. (G) Kinetics of 
transient pupil constriction (100 lux) in mice with only rod, cone, or melanopsin function, 
same genotypes and number of animals as in F. Traces of individual mice are shown 
behind curve-fits. One-phase decays were fit to all except cone-only which was fit with a 
two-phase decay due to its rapid pupil decay within 30s. Melanopsin-only kinetic fit was 
offset from 0 by 3 sec to account for delay in constriction. See also Figure 2—figure 
supplement 1, Figure 2—figure supplement 2, Figure 2—figure supplement 3, 





Figure 2—figure supplement 1: Dark-adapted pupil sizes of photoreceptor mutant 
mouse lines used. 
Dark-adapted pupil sizes of all mouse lines used for photoreceptor investigation. Pupil 
size was recorded before light onset and pupil area (mm2) is reported. No statistical 
difference was found for any genotype compared to wildtype (P > 0.05 for all 






Figure 2—figure supplement 2: Rods are required for the transient phase of the 
PLR.  
(A) Diagram of the retina labeling the photoreceptors. For experiments in B–D, WT n = 
14, Opn4-/- n = 8, Cnga3-/- n = 4, Gnat2-/- n = 7, Cone-DTA n = 7, Gnat1-/- n = 6, Rod-
DTA n = 9. (B) Kinetics of rapid constriction in response to dim light (10 lux).  Rod KO 
mice are the only photoreceptor mutants to display a deficit. Cone and Mel. KO mice are 
identical to wildtype. (C) Intensity-response curves of the PLR in each of the 
photoreceptor mutant mouse lines (mean ± SD). The bar on top of the figure denotes the 
estimated sensitivities of rods and cones. (D) Rod mutant animals are the only mutants 
that display a sensitivity (EC50) deficit compared to WT (P < 0.0001). In fact, Cone-DTA 
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mice are moderately more sensitive than WT (* P = 0.011). Points indicate individual 
mice, line indicates mean. Statistical significance determined using a one-way ANOVA 





Figure 2—figure supplement 3: Melanopsin is not required for transient PLR in 
response to environmentally relevant overhead light. 
 Transient PLR determined under 3 different experimental light conditions. (Left) Blue 
(474-nm) LED light presented to contralateral eye (1.9x1016 photons/cm2/s). (Middle) 
White halogen light presented to contralateral eye (27.58 W/m2). (Right) 1000 lux white 
compact fluorescent light presented overhead to both eyes (4.4 W/m2). Line represents 
mean and points are individual mice. Statistical significance determined by one-way 
ANOVA followed by Sidak’s post-test. No difference observed when light presented 





Figure 2—figure supplement 4: Rod input to the transient PLR is influenced by 
cones.  
(A) Cartoon representation of a cone and a diagram of its phototransduction cascade. 
Different aspects of this cascade are disrupted in the various ‘rod-only’ lines we use. (B) 
Multiple mouse lines with rods as the only functional photoreceptors. For the 
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experiments in C and D: WT n = 6, Rod-only type 1 (RO1: Cnga3-/-; Opn4-/-) n = 6, Rod-
only type 2 (RO2: Gnat2-/-; Opn4-/-) n = 8, Rod-only type 3 (RO3: Cone-DTA; Opn4-/-) n 
= 5. (C) Intensity-response curve of the PLR in all of the rod-only lines, which are all 
similar to wild-type at all light intensities (mean ± SD). At 1000 lux, only RO2s are 
statistically different from wildtype (P = 0.006 by one-way ANOVA with Sidak‘s post-
test). (D) Sensitivity (EC50) in each of the mutant lines. No statistical differences were 
observed between the mouse lines (compared to WT, RO1 P = 0.956, RO2 P = 0.340, 
RO3 P = 0.141 using a one-way ANOVA with Sidak’s post-test), although the RO2 line 
had more variability and trended toward lower sensitivity. (E and F) Kinetic comparison 
of rod-only lines at dim (E) and bright (F) light intensities. RO1 and RO3 lines are 
identical to wildtype under both light intensities, however, RO2 mice display PLR decay 






Figure 2—figure supplement 5: Melanopsin can drive rapid constriction at high 
light intensities.  
Multiple mouse lines with ipRGCs as the only functional photoreceptors (melanopsin-
only) or a mouse line with cones as the only functional photoreceptors (cone-only) were 
tested. For the experiments in A and B: WT n = 9, Gnat1-/- n = 10, Melanopsin-only type 
1 (MO1: Gnat1-/-; Cnga3-/-) n = 7, Melanopsin-only type 2 (MO2: Gnat1-/-; Gnat2-/-) n = 
9, Melanopsin-only type 3 (MO3: Rod-DTA; Cone-DTA) n = 6, Cone-only (Gnat1-/-; 
Opn4-/-) n = 6. (A) Intensity-response curve of the PLR in all of the melanopsin-only 
lines and in the cone-only mouse line (mean ± SD). (B) EC50 in each of the lines. All 
mutant lines are less sensitive than WT (P < 0.0001) by >2 log units. Cone-only mice are 
additionally less sensitive than Rod KO mice (P < 0.0001), but no melanopsin-only line 
is significantly different from Rod KO (Compared to RKO: MO1 P = 0.201, MO2 P = 






Figure 3: Glutamaterigic output provides precise and rapid transient signaling. 
(A) Diagram of ipRGC behavioral circuit. (B) Intensity-response curves of the PLR in 
each of the neurotransmitter mutant mouse lines (Wildtype n = 6)(ipRGC glu. KO: 
Opn4Cre/+; Slc17a6fl/fl n = 4)(ipRGC PACAP KO: Opn4Cre/+;Adcyap1fl/- n = 6)(mean ± 
SD). (C) Sensitivity (EC50) in each of the mutant lines. Statistical significance determined 
by one-way ANOVA with Sidak’s post-test. (D) Kinetics of transient pupil constriction 
(1000 lux) in mice lacking glutamatergic or PACAPergic neurotransmission. Traces of 
individual mice are shown behind one-phase decay curve-fits. Half-lives: Wildtype (1.1 
sec), ipRGC glu. KO (4.8 sec), ipRGC PACAP KO (1.1 sec). (E) Representative pupil 
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images at 5 sec and 30 sec post-illumination (1000 lux). Figure 3—figure supplement 1, 





Figure 3—figure supplement 1: Dark-adapted pupil sizes of neurotransmitter 
mutant lines used. 
 Dark-adapted pupil sizes of all mouse lines used for neurotransmitter investigation. Pupil 
size was recorded before light onset and pupil area (mm2) is reported. ipRGC glutamate 
KO mice are the only line used which display a significant difference in dark-adapted 
pupil size suggesting that glutamatergic signaling is important for setting pupil size in 
darkness (P = 0.0001). Statistical significance was determined by one-way ANOVA 






Figure 3—figure supplement 2: Description of conditional PACAP allele.  
Schematic of the conditional PACAP allele (Adcyap1lox). Boxes indicate exons (1-5). 
Grey indicates UTR while black indicates protein coding sequence. A single FRT site 
remains after removal of selection cassette. LoxP sites flank exon 2. Cre-mediated 
excision results in a frameshift and production of a truncated protein. See Methods and 
Materials for further information of allele generation and confirmation. A more detailed 
description of the generation and use of the allele will appear in a manuscript that is in 





Figure 3—figure supplement 3: PACAP can drive significant constriction within 30s 
of high light onset.  
Transient constriction was monitored in neurotransmitter mutant mice under high light 
(5000 lux). Data from each mouse is shown with the mean (black bar). ipRGC glutamate 
KO mice (Opn4Cre/+; Slc17a6fl/fl : n = 4) display a significant reduction in transient phase 
pupil constriction compared to wildtype (n = 6)(P < 0.0001) while ipRGC PACAP KO 
(Opn4Cre/+;Adcyap1fl/- : n = 6) and PACAP KO (n = 4) mice are indistinguishable from 
wildtype (P > 0.999). Statistical signficance determined via one-way ANOVA followed 





Figure 4: Melanopsin/rod synergy supports PLR under persistent conditions.  
(A) Diagram of ipRGC behavioral circuit. (B) Intensity-response curves for wildtype and 
melanopsin knockout mice (Opn4-/-): transient (dotted lines for reference) and sustained 
(60 minutes: solid lines) (WT n = 6, Opn4-/- n = 12). (right) Representative pupil images 
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under 1000 lux persistent light. (C) 60-min time course of pupil constriction under 
constant light (1000 lux). Data fit with a one-phase association curve (WT n = 5, Opn4-/- 
n = 7). (D) Sustained pupil constriction monitored every 5 minutes for 1 hour in 
melanopsin knockout mice (Opn4Cre/Cre) expressing the Gq-coupled DREADD (hM3D) 
specifically in ipRGCs (AAV2-hSyn-DIO-hM3D(Gq)-mCherry). CNO injection IP (blue) 
caused robust constriction within 5–10 minutes that was sustained for 60 minutes, 
whereas PBS injection (black) did not. CNO data is fit with a one-phase association curve 
and PBS data is fit with a linear regression (n = 6, mean ± SD). (E) (top) Diagram 
showing viral eye injection in only one eye. (bottom) Confocal microscope images of an 
Opn4Cre/Cre retina injected with AAV2-CMV-DIO-mRuby-P2A-Melanopsin-FLAG 
showing infection and expression (mRuby, top; anti-OPN4, bottom). Scale bar = 50 µm. 
(F) Successful rescue of pupil constriction by virally restored melanopsin expression in a 
single eye of adult mice (WT n = 6, Mel. KO n = 12, Mel.-Rescue n = 4). (right) 
Representative pupil images of Mel. KO and Mel.-Rescue mice at 1000 lux. (G) PLR 
intensity-response curves of Wildtype (n = 6), Mel.-only (Rod-DTA; Cone-DTA n = 8), 
Cone KO (Cnga3-/-  n = 4), and Rod KO (Rod-DTA n = 5) mice (mean ± SD). 
Melanopsin is sufficient at high light (≥1000 lux), however, rods are required at lower 
light intensities. Cone KO mice are similar to wildtype. (top) Representative pupil images 
at 1000 lux. See also Figure 4—figure supplement 1, Figure 4—figure supplement 2, 





Figure 4—figure supplement 1: Melanopsin is required for sustained constriction 
across the day.  
(A) Sustained constriction at 10,000 lux (WT n = 6, only 1 is plotted due to inability to 
see extremely small pupils in very bright light, Mel. KO n = 6). (B) Time course of pupil 
constriction under 12 hours of constant light corresponding to circadian day (room 







Figure 4—figure supplement 2: Viral infection and expression is specific to ipRGCs.  
(A) Schematic of the method to activate exclusively ipRGCs using an exogenous GPCR 
(hM3D(Gq)) and its ligand (CNO). (B) Confocal microscope image showing infection of 
ipRGCs observed by mCherry expression following administration of a Cre-dependent 
AAV injected into the vitreous of melanopsin-Cre knockout mice (Opn4Cre/Cre). (C-E) 
Confirmation of ipRGC-specific expression of melanopsin from AAV-DIO-mRuby-P2A-
Melanopsin-FLAG viral injections. Opn4Cre/+ mice were used to colocalize viral (C) 
mRuby with (D) endogenous and exogenous melanopsin expression. (E) We observe 
specific expression of mRuby in a significant portion of ipRGCs, although some ipRGCs 
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lack mRuby staining, presumably due to lack of infectivity (arrows show mRuby-
negative ipRGCs). Scale bars = 50 μm. (F) Quantification of fraction of ipRGCs 
(melanopsin-antibody) which are mRuby-positive. Quantification shown for three mice 
(A single 20x field was quantified for each mouse). Approximately 90% of melanopsin-






Figure 4—figure supplement 3: Rods, but not cones, contribute to sustained PLR 
sensitivity.  
(A) PLR intensity-response curves of wildtype and mice with only melanopsin 
phototransduction intact (‘melanopsin-only’: Gnat1-/-; Gnat2-/- n = 4, Gnat1-/-; Cnga3-/- n 
= 4, Rod-DTA; Cone-DTA n = 8) (mean ± SD). (B) Sustained PLR intensity-response 
curves of wildtype (n = 11) and rod mutant mice (Gnat1-/- n = 5, Rod-DTA n = 5) (mean 
± SD). (C) Sustained PLR intensity-responses of wildtype and cone mutant mice (‘cone 
mutants’: Gnat2-/- (n = 4), Cnga3-/- (n = 4), Cone-DTA (n = 4)). (D) Sustained EC50 for 
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wildtype and cone mutant, rod mutant and melanopsin-only mice (line = mean). All rod 
mutant and melanopsin-only mouse lines display significnt loss of sensitivity (P < 
0.0001). Two of three cone mutant mouse lines were not significantly different from 
wildtype (Cnga3-/- P = 0.57, Cone-DTA P > 0.999), though Gnat2-/- displayed a 0.69 log-
unit decrease in sustained PLR EC50 (Gnat2
-/- P = 0.004). Additionally, all rod mutant 
lines were similar to their corresponding melanopsin-only line (P  > 0.706) while all cone 
mutant lines were significantly more sensitive than their corresponding melanopsin-only 






Figure 4—figure supplement 4: Rods drive the residual sustained pupil constriction 
observed in the absence of melanopsin.   
(A) Sustained PLR dose-responses for wildtype (n = 11), melanopsin knockout (Opn4-/-, 
n = 12) and mice with only rod phototransduction intact (‘rod-only’: Cnga3-/-; Opn4-/- n = 
4) (mean ± SD). (right) Scatter plot of 1000 lux sustained PLR. Melanopsin knockout and 
‘rod-only’ mice not statistically different by one-way ANOVA with Sidak’s post-test (P 
= 0.983) (line indicates mean). (B) Sustained PLR intensity-responses for wildtype (n = 
11), melanopsin knockout (Opn4-/- n = 12) and mice with only cone phototransduction 
intact (‘cone-only’: Opn4-/-; Gnat1-/-, n = 6, mean ± SD). (right) Scatter plot of 1000 lux 
sustained PLR. Melanopsin knockout and ‘cone-only’ mice are statistically different by 





Figure 5: PACAP is essential for the sustained PLR.  
(A) Diagram of ipRGC behavioral circuit. (B) PLR intensity-response curves of sustained 
constriction in mice lacking glutamatergic or PACAPergic neurotransmission (WT n = 6, 
ipRGC glu. KO n = 4, ipRGC PACAP KO n = 6)(mean ± SD). Both mutants display 
deficits at 10, 100, and 1000 lux as compared to wildtype (wildtype v. ipRGC Glu. KO: 
10 and 100 lux P < 0.0001, 1000 lux P = 0.0004 by two-way ANOVA with Sidak’s post-
test)( wildtype v. ipRGC PACAP KO: 10, 100, and 1000 lux P < 0.0001 by two-way 
ANOVA with Sidak’s post-test). (C) Representative pupil images of sustained 
constriction at 1000 lux. (D) Comparison of transient and sustained constriction under 
high light (1000 lux). ipRGC glu. KO mice (red) show an increase in pupil constriction 
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with time whereas ipRGC PACAP KOs (blue) display a significant loss of constriction 
over time (ipRGC glu. KO transient v. sustained P < 0.0001, ipRGC PACAP KO 
transient v. sustained P = 0.0003, wildtype transient v. sustained P = 0.9921 by one-way 
ANOVA with Sidak’s post-test). (E) Pupil constriction of neurotransmitter mutant mice 
after sustained 5000 lux light. Data from individual mice shown with mean (black bar). 
Statistical significance determined by one-way ANOVA with Sidak’s post-test. See also 






Figure 5—figure supplement 1: PACAP KO mice display similar PLR phenotypes 
to ipRGC-specific PACAP KO mice.  
(A) Intensity-response curves of the transient PLR (30s light) in each of the 
neurotransmitter mutant mouse lines (Wildtype n = 6)(ipRGC glu. KO: Opn4Cre/+; 
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Slc17a6fl/fl n = 4)(PACAP KO: Adcyap1-/- n = 4)(mean ± SD). (B) Sensitivity (EC50) in 
each of the mutant lines. Statistical significance determined by one-way ANOVA with 
Sidak’s post-test. (C) Comparison of transient and sustained (60 min. light) constriction 
under high light (1000 lux). ipRGC glu. KO mice (red) show an increase in pupil 
constriction with time whereas PACAP KOs (blue) display a significant loss of 
constriction over time. (D) PLR intensity-response curves of sustained constriction in 
mice lacking glutamatergic or PACAPergic neurotransmission (WT n = 6, ipRGC glu. 
KO n = 4, PACAP KO n = 4)(mean ± SD). Both mutants display similar deficits until 
1000 lux where PACAP KO mice show a further deficit (PACAP KO v. ipRGC Glu. KO: 
P = 0.0019 by one-way ANOVA with Sidak’s post-test). (right) Representative pupil 
images of sustained constriction at 1000 lux. (E) Pupil constriction of neurotransmitter 
mutant mice after sustained 5000 lux light. Data from individual mice shown with mean 
(black bar). Statistical significance determined by one-way ANOVA with Sidak’s post-
test. (F) 60-min. time course of pupil constriction under constant light (1000 lux). Data fit 





Figure 6: Model of ipRGC circuit transitions.  
(A and B) Heat maps of (A) transient and (B) sustained PLR as duration and intensity 
vary. Night, dawn/dusk, and daytime light intensities indicated by ticks on right side of 
plot. (top) Heat maps of individual photoreceptor contributions (grayscale). Black 
represents no contribution and degree of white represents increasing contribution. Each 
photoreceptor contribution heat map is a combination of necessity (individual 
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photoreceptor transduction knockouts) and sufficiency (‘photoreceptor-only’) heat maps 
(for example: Input Contributionrod = Max(Necessityrod, Sufficiencyrod)). (middle) Rod 
(red), cone (green), melanopsin (blue) contributions are combined into a single heat map. 
(bottom) Color combination guide for reference when viewing heat map. (C and D) Same 
as above for neurotransmitter contributions to transient (C) and sustained (D) ipRGC 
signaling. Glutamatergic contribution is in green and PACAPergic contribution is in blue. 
See the Materials and Methods section for details on heat map generation. Note that the 







Figure 6—figure supplement 1: Necessity/Sufficiency heat maps for photoreceptor 
input to pupil constriction.  
Heat maps of necessity and sufficiency of each input (top: rods, cones, melanopsin) as 
stimulus duration and intensity vary. The necessity/sufficiency heat maps for a particular 
component were subsequently used to generate a photoreceptor contribution heat map 





Mouse line Genotype Effect on retinal function Citations 
Rod KO Gnat1-/- No rod phototransduction 84 
Rod-DTA rdta 
No rod cell bodies; cones present 
early in life 
 
Cone KO1 Cnga3-/- No cone phototransduction 54 
Cone KO2 Gnat2cpfl3/cpfl3 No cone phototransduction 85 
Cone-DTA h.red DT-A 
Ablation of all M cones; >95% loss of 
S cones 
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No rod or cone cell bodies  
Red cone KI Opn1mwred Cones have shifted sensitivity to red 87 




Cones have shifted sensitivity to red, 








Mouse line Genotype Effect on retinal function Citations 
Melanopsin-Cre Opn4Cre/+ Cre expression in ipRGCs 88 





Silences ipRGC glutamatergic 
release 
 
PACAP KO Adcyap1-/- Whole animal PACAP removal 90 

















Chapter 3: Glutamatergic ipRGC signaling 






 Constriction and dilation of the pupil provides the visual system with a way to 
regulate the amount of light entering it. The neural circuits responsible for pupil 
constriction in response to light increments have seen extensive research and insight, 
however, little work has been done to understand pupil dilation in response to light 
decrements. IpRGCs relay light information from the retina to areas controlling pupil size 
and have been shown to be critical relays for light information to drive pupil constriction. 
In this chapter, we investigate the role of ipRGCs in pupil dilation. Using mice lacking 
ipRGC-glutamatergic or PACAPergic neurotransmission, we asked whether pupil 
dilation is an active process and which neurotransmitters support it. In this study, we 
show that pupil dilation in response to dimming light is, in fact, an active process which 
requires glutamatergic neurotransmission from ipRGCs. 
 
Introduction 
 Pupil constriction and dilation are equally important aspects of pupillary control. 
While the mechanisms underlying pupil constriction have been the topic of a significant 
amount of research (including our own – See Chapter 2), pupil dilation has received 
remarkably little attention.  In fact, I am unaware of a single study on the mechanisms 
underlying dilation since the dawn of modern genetic tools in mice.  
 The iris consists of two components: the inner sphincter muscle (constrictor) and 
the outer radial muscle (dilator). The constrictor is innervated by parasympathetic fibers 
and the dilator by sympathetic fibers. The pupil constricts as a result of parasympathetic 
constrictor activation and concomitant relaxation of the dilator. The fundamental cause of 
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pupil dilation in response to dimming light is less clear. Whether it is caused by passive 
relaxation of the constrictor or activation of the dilator is an open question even after 
hundreds of years of pupil research 52,91. 
 I became interested in pupil dilation after an observation made while asking 
questions about pupil constriction (Chapter 2). As a control experiment, I measured the 
resting pupil size (dark-adapted for 1 hour) of all the mouse lines I had used. 16 of the 17 
lines had indistinguishable baseline pupil sizes, however, 1 of them, ipRGC glutamate 
KOs (Opn4Cre ; Vglut2fl/fl), had a significantly smaller pupil (~30%)(see Chapter 2: 
Figure 2—figure supplement 1, Figure 3—figure supplement 3). In fact, a previous 
study noticed a similar trend when they tested this mouse line92, although it was not 
statistically significant. 
 The first and most obvious explanation for the small resting pupil size is defective 
dilation. One would expect that decreased dilation drive in response to darkness would 
lead to an overall smaller pupil size. To answer this question, I performed similar 
experiments to those described in chapter 2 with a focus on the offset of light stimulus 
and subsequent pupil dilation.  
 
Results 
Mice lacking ipRGC-glutamatergic signaling have massively reduced pupil dilation 
kinetics 
Given the smaller dark-adapted pupil size of mice lacking glutamatergic signaling 
from ipRGCs (Chapter 2: Figure3—figure supplement 3), we asked whether these 
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mice have deficits in pupil dilation after light dimming. To do so, we submitted wildtype 
and ipRGC-glu. KO mice to 30 seconds of light (6500K, 1000 lux) followed by 10 
seconds of darkness. During the 30 second light stimulus, we observed constriction in 
both wildtype and ipRGC-glu. KO mice, albeit reduced in amplitude (See Chapter 2 for 
initial characterization of these mice). While wildtype mice displayed a significant 
amount of dilation within the 10 seconds after light offset, ipRGC-glu. KO mice showed 
little to no change in pupil size (Figure 1). This suggests that glutamatergic 
neurotransmission from ipRGCs is critical for dilation in response to darkness, at least 
over short timescales. 
To determine whether glutamate is required for dilation over longer timescales as 
the reduced resting pupil size suggests, we sought to observe dilation for a more extended 
duration. We are limited in our continuous pupil observation by the duration a mouse will 
tolerate scruffing. This tends to be somewhere between 1 and 3 minutes. To maximize the 
amount of dilation we can observe, we first light-adapted mice for 60 minutes under 
bright light (6500K, 1000 lux). We then began our observation with 5 seconds of light to 
determine the extent of constriction achieved during light adaptation followed by a 60 
second window of darkness/dilation (Figure 2). Wildtype mice’s pupils dilated 
extensively over the 60 seconds of darkness – from 10% to 78% of resting pupil size. 
IpRGC-glu. KO mice, however, displayed little to no response to light offset – mean 
pupil size moved from 28% at light offset to 32% given 60 seconds of darkness (Figure 
2). We also tested PACAP KO mice (Adcyap1-/-) and observed marked dilation – 45% to 
84% of resting pupil size. Note that PACAP KO mice started with less constriction due to 
their sustained pupil constriction deficit (See Chapter 2 for initial characterization of 
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these mice). These results highlight and strengthen the specific role glutamatergic 
neurotransmission plays in pupil dilation even more so than pupil constriction (Chapter 
2).  
Given the drastic pupil dilation deficit we observed over the 60 second dilation 
time course and the fact that these mice do eventually reach a more dilated resting pupil 
size, we performed a long-term pupil dilation time course spanning several hours (Figure 
3). In this experiment, we light-adapted mice as before and then tracked dilation with 30 
second discontinuous observations at 1, 5, 10, 60, 90, 120, and 180 minutes post light 
offset. Wildtype mice returned to their resting pupil size within the first 10 minutes of 
observation, however, ipRGC glu. KO displayed an incoherent pattern of pupil size 
fluctuation (Figure 3). Even during the 30 second observations, fairly rapid fluctuations 
were observed (data not shown). It appears that glutamate is required for coherent 
dilation of the pupil at short and long timescales. Further observation with more mice and 




 The results presented in this chapter highlight how little we know about the 
process of pupil dilation. We have shown that dilation must be an active process which 
depends on ipRGCs’ glutamatergic neurotransmission.  
There are many fundamental questions to answer before we can begin to 
understand dilation to the extent of constriction. First and most important is discovering 
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the brain nucleus responsible for receiving darkness information and driving pupil 
dilation. The only lead derives from a 1985 study by R. J. Clarke and H. Ikeda which 
demonstrates the presence of cells activated by darkness in the posterior pretectal nucleus 
(PPN)93. Fittingly, this study also revealed luminance detectors in the nearby OPN known 
to control pupil constriction. However, no further investigation of the PPN has been done 
to confirm its role in pupil dilation.  
Once we have the target neuronal population, we can begin to investigate the 
molecular mechanisms underlying their response to glutamate. Because ipRGCs are 
known to increase activity in light and decrease activity in darkness, these central target 
neurons must somehow invert the glutamatergic signal they are receiving. Strong basal 
activity coupled with expression of an inhibitory glutamate receptor could achieve this 
goal. Strong inhibition would reduce dilator activation in the presence of light and allow 
for robust pupil constriction. Darkness would lift inhibition of these neurons subsequently 




C57Bl/6 × Sv129 hybrid mice were used in all experiments except PACAP KO 
mice which were C57Bl/6. All mice were housed according to guidelines from the 
Animal Care and Use Committee of Johns Hopkins University. Male and female mice 
age 4-8 months were housed in plastic translucent cages with steel-lined lids in an open 
room. Ambient room temperature and humidity were monitored daily and tightly 
controlled. Food and water were available ad libitum. All mice were maintained in a 
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All mice were dark-adapted for at least 12 hours prior to any experiments and all 
PLR experiments were performed between Zeitgeber times (ZT) 2 and 10. For all 
experiments, mice were unanesthetized and restrained by hand. Because stress can affect 
pupil size, we ensured that the mice were not stressed during these experiments. To do so, 
we handled the mice for several days prior to the experiments to get them accustomed to 
the researchers and to being scruffed. Any mice that showed signs of stress, including 
vocalizations and wriggling during the experiments, were not used and were subjected to 
more handling sessions before use in experiments.  
Mice were restrained manually under a 23-Watt compact fluorescent light bulb 
(GE Daylight FLE10HT3/2/D or Sylvania Daylight CF13EL and CF23EL) with a color 
temperature of 6500 K to simulate natural sunlight. The light intensity was measured 
using a light meter (EXTECH Foot Candle/Lux Light Meter, 401025) at the surface on 
which the mouse was held. The light meter was initially calibrated by EXTECH using a 
Tungsten 2856 K light source; because our experiments used a fluorescent bulb of 6500 
K, all measured light intensities reported here may vary by 0.92–1.12 times the actual 
light intensity.  
Videos of the eye were taken using a Sony Handycam (DCR-HC96) mounted on 
a tripod a fixed distance from the mouse. Manual focus was maintained on the camera to 
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ensure that only one focal plane existed for each mouse and that therefore variable 
distance from the camera should not contribute to differences in relative pupil area 
throughout the video. Pupil size was first recorded under dim red light and the 
endogenous infrared light source of the camera to capture the dark-adapted pupil size. 
Pupils were recorded either at the initial onset of light and offset 30 seconds later or mice 
were adapted to 1000 lux light for 1 hour followed by pupil monitoring at light offset. All 
pupil images were cropped to a fixed square area surrounding the eye using GNU Image 
Manipulation Program (GIMP). The images were made grayscale and then brightness and 
contrast were adjusted to enhance visibility of the pupil and exported as PNG files.  
 
Data analysis  
Videos were transferred from the camera to a computer as Audio Video Interleave 
(AVI) files and individual frames were taken using VLC media player 
(www.videolan.org/vlc/) and saved in portable network graphics format (PNG). Images 
were taken in the dark, at 5 seconds, and 30 seconds following stimulus onset. Pupil area 
was then quantified manually in ImageJ (http://rsbweb.nih.gov/ij/) software. The pupil 
area was measured in pixels using the oval tool in which the 4 cardinal points of the oval 
were touching their respective edges of the pupil. The relative pupil area was calculated 
using LibreOffice Calc or Microsoft Excel in which the area during the light stimulus was 
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Figure 1: Glutamatergic signaling is required for rapid pupil dilation.  
30 seconds of 1000 lux overhead light (6500K) followed by 10 seconds of darkness was 
performed on wildtype and ipRGC-glu. KO mice (Wildtype n = 8, ipRGC glu. KO: 
Opn4Cre/+; Slc17a6fl/fl n = 4)( mean ± SD). The shaded region indicates darkness. Little 






Figure 2: Dilation over longer timescales requires ipRGC glutamate.  
60 minutes of 1000 lux overhead light (6500K) was followed by 60 seconds of darkness 
(Wildtype n = 8, ipRGC glu. KO: Opn4Cre/+; Slc17a6fl/fl n = 4, ipRGC PACAP KO: 
Adcyap1-/- n = 4)(mean ± SD). The shaded region indicates darkness. Wildtype and 
PACAP KO mice dilate to near dark-adapted pupil size within the 60s of darkness. 
However, ipRGC glu.-KO mice display sustained constriction in the absence of light with 






Figure 3: Long-term dilation is incoherent in the absence of glutamatergic signaling. 
60 minutes of 1000 lux light (6500K) followed by 3 hours of darkness (Wildtype n = 1, 
ipRGC glu. KO: Opn4Cre/+; Slc17a6fl/fl n = 3) (Traces show individual mice). The shaded 
region indicates darkness. Each data point is the result of 30 second observation of that 
mouse at that time. The minimum pupil size during that window was reported. Wildtype 
returned to pre-light pupil size within first 10 minutes of darkness. IpRGC glu. KO mice 
showed variable responses that were erratic during the 30 second observation windows. 
A trend toward dilation is observable in these mice over the course of the 3 hours of 





Chapter 4: Discovery and characterization of 
novel ipRGC neurotransmitters 
 
This chapter is based on a manuscript in preparation: 
William T Keenan, Michael Thomsen, and Samer Hattar. Discovery and 





 Intrinsically photosensitive retinal ganglion cells (ipRGCs) coordinate a variety of 
physiological responses to light such as sleep/wake, pupil size, and mood. This small 
subset of retinal output neurons signal to the brain with two neurotransmitters: glutamate 
and PACAP. Both neurotransmitters support communicating distinct aspects of the light 
environment. Glutamate conveys rapid and robust responses to light dynamics while 
PACAP supports sustained changes over longer durations. In this chapter, we show that 
there is likely another neurotransmitter employed by ipRGCs and go on to characterize 
several candidate neurotransmitters and identify two new neuropeptides expressed by 
subsets of ipRGCs – Substance P (Tac1) and Somatostatin (Sst). Substance P expressing 
ipRGCs project to the OPN – the pupil control center of the brain making it a promising 
candidate for pupil regulation. Somatostatin is expressed in a small subset of ipRGCs 
which line the ventral periphery of the retina and may play a role in intraretinal 
modulation. Further work on both novel neurotransmitters is required to determine their 
functional role in the visual system. 
 
Introduction 
 Since the initial discovery of ipRGCs, they have been thought to uniquely express 
two neurotransmitters: glutamate and PACAP9,14,15. Several studies since have shed light 
on the contributions of each neurotransmitter molecule to ipRGC-dependent function42–
44,46–50,92,94. In Chapter 2, we showed that the primary difference between glutamate and 
PACAP is time. Glutamate is used to communicate rapid changes and fluctuations in 
light over milliseconds to seconds, and PACAP communicates long-term changes in the 
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light environment on the scale of minutes to hours. All of these studies, including our 
own, have been limited in their conclusions because the field has yet to demonstrate 
glutamate and PACAP to be the complete set of neurotransmitters used by ipRGCs.  
In this study, we demonstrate the existence of novel ipRGC neurotransmission in 
the absence of glutamate and PACAP and begin its identification and characterization. 
 
Results 
Persistent PLR in the absence of glutamatergic and PACAPergic neurotransmission 
 To determine if glutamate and PACAP account for all ipRGC neurotransmission, 
we created a mouse lacking both – ipRGC glutamate/PACAP double knockouts 
(Opn4Cre/+ ; Vglut2fl/fl ; PACAP-/-)(See Chapter 2 for details on each allele). When we 
assayed rapid pupil constriction in these mice, we saw a response similar to that of the 
ipRGC glu. KO alone (Figure 1). As a negative control, we tested mice expressing 
Tetanus toxin in ipRGCs to silence all forms of neurotransmission indiscriminately 
(Opn4Cre/+ ; TeNT)(Jax strain # 010713), and observed complete loss of pupil 
constriction (Figure 1). Together, these results suggest that glutamate and PACAP do not 
account for all ipRGC-elicited responses (Figure 2). We next endeavored to find and 
characterize this/these novel ipRGC neurotransmitter(s). 
Several candidate ipRGC neurotransmitters have Cre lines available 
 A collection of works characterizing novel neurotransmitter expression in the 
retina81,95–98 pointed us toward 20 candidate ipRGC transmitters (Figure 3). 10 of these 
have readily available Cre (Cck, Crh, Pdyn, Penk1, Oxt, Tac1, Sst, Avp, CART) or 
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transgenic reporter (NPY) lines making it simple to determine whether they label 
ipRGCs. To date, I have looked at Cck, Crh, Pdyn, NPY, Penk1, Tac1, Sst, and CART, 
but I will only cover those that are furthest along in this chapter. The approach consists of 
mating a neuropeptide Cre line to the Cre-dependent YFP reporter line (Jax #006148) and 
visualizing ipRGCs with Melanopsin antibody. 
Neuropeptide Y (NPY) 
 NPY is a 36 amino acid peptide involved in regulation of stress, anxiety, food 
intake, circadian rhythms, cognition, and energy homeostasis99. In order to visualize cells 
expressing NPY in retina, I made use of a transgenic NPY reporter mouse line: tg(NPY-
GFP)100. Observing a wholemount tg(NPY-GFP) retina revealed abundant populations of 
labeled cells in the ganglion cell layer (GCL) and the inner nuclear layer (INL)(Figure 
4A). In order to differentiate ganglion cells from other cells types in the GCL, we stained 
reporter retinas with an RBPMS antibody (Millipore ABN1362) which labels all ganglion 
cells (Figure 4B). The vast majority NPY-positive cells were non-ganglion cells (RBPM-
negative) and all strongly NPY-positive cells were non-ganglion cells. A small 
population of weakly reporting cells were RPBMS-positive. To test whether these 
ganglion cells are ipRGCs we stained tg(NPY-GFP) retinas for Melanopsin and observed 
no NPY-positive ipRGCs (Figure 4C). NPY does not appear to label any Melanopsin-
antibody positive ipRGCs. 
 
Tachykinin 1 (Tac1) 
 The Tac1 locus produces 4 peptides – Substance P, NKA, NPK, and NPγ – but 
the locus is predominantly known for producing Substance P101.  I made use of a Cre line 
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(Tac1IRES-Cre)102 available from Jax (#021877). Tac1Cre;YFP label a wide variety of cell 
types in the ganglion cell layer including glial cell types such as astrocytes and 
oligodendrocytes (identifiable by morphology)(Figure 5A). Both ganglion cells 
(RBPMS-positive) and non-ganglion cells are labeled in Tac1 reporter retina (Figure 
5A). Of these Tac1-positive ganglion cells, some of them are also Melanopsin-antibody 
positive (Figure 5B). 
YFP-positive cells are not necessarily expressing Cre in adulthood. Any cell 
which expressed Tac1 at any point in its life will be labeled with YFP in these lines. In 
order to determine whether Tac1-positive ipRGCs are expressing Tac1-Cre in adulthood 
as opposed to during development, I took advantage of a Cre-dependent reporter virus 
(AAV2-DIO-mCherry). Injecting this virus in adulthood allows for visualization of cells 
currently expressing Cre. Cre-dependent AAV injection reveals Tac1-positive ipRGCs 
actively expressing Cre (Figure 5C). These results reveal a novel neurotransmitter 
system in ipRGC: Substance P and the other Tac1 peptides. Further work will need to be 
done to determine the role of these peptide in ipRGC-dependent functions. 
 A first step toward understanding Tac1-positive ipRGCs is to determine where 
these cells project in the brain. For instance, if Tac1 peptides are responsible for the pupil 
constriction we observed in the absence of glutamate and PACAP then Tac1-ipRGCs 
should project to the OPN. The Cre-dependent AAV-mCherry also serves as a great way 
of visualizing the projections of Tac1-positive RGCs in the brain. Looking at projections, 
we observe strong labelling in the OPN, sparse labelling in the LGN, and little to no 
labeling in the SC and SCN (Figure 6). This provides further evidence for the possibility 
that Tac1 peptides are involved in PLR and may potentially be the source of our observed 
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residual pupil constriction. Irrespective of their role in the PLR, Tac1 labels a novel 
subset of ipRGCs and further characterization is critical to understanding the ipRGC 
system. 
Somatostatin (SST) 
 Sst is a peptide commonly known to inhibit the release of downstream hormones 
and signals such as growth hormone and glucagon103. Sst has two critical mouse lines – a 
Cre knockin (Jax #013044) and a FLP knockin (Jax #028579). Sst-Cre;YFP retinas show 
sparse populations of cells in the GCL and INL (Figure 7). The majority of cells in the 
GCL are ganglion cells (Figure 7A), determined by expression of RBPMS. Additionally, 
a very small number of these cells are Melanopsin antibody positive ipRGCs (Figure 7B) 
revealing another novel ipRGC neurotransmitter and ipRGC subtype.  
An interesting but unrelated observation in Sst-Cre;YFP retinas is the presence a 
small population of labeled horizontal cells (Figure 8). This is a particularly important 
observation because mice are thought to have only 1 type of horizontal cell104. Further 
investigation of these cells may reveal previously unappreciated diversity among 
horizontal cells. 
The Sst-FLP mouse line gives us the opportunity to investigate somatostatin 
expressing ipRGCs with much higher sensitivity than allowed by Melanopsin antibody 
by coupling Sst-FLP, Melanopsin-Cre, and a dual-recombinase reporter line105 
(RC::FLTG – Jax #026932)(Figure 9). The RC::FLTG allele reports FLP-positive cells 
with tdTomato and FLP/Cre double positive cells with eGFP (Figure 9A). Using this 
system, we achieve genetic sensitivity as opposed to being limited by the sensitivity of 
the Melanopsin antibody. In the GCL of Sst-FLP;Opn4-Cre;RC::FLTG retinas we 
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observe a sparse population of FLP-only cells and an even sparser population of FLP/Cre 
cells (I will call these cells Sst-ipRGCs) (Figure 9B). 
We next visualized Sst-ipRGCs within a whole retina to get an idea of their 
numbers and distribution (Figure 10). Roughly 100-150 Sst-ipRGCs populate each retina 
(only 1 is shown with 140 cells) which is an incredibly small subset of ipRGCs: about 3% 
of all ipRGCs. These Sst-ipRGCs display a clear dorsal-low to ventral-high gradient 
visualized by heatmap and a clear preference for the periphery of the retina (Figure 10). 
We performed the same analysis of FLP-only cells and see a similar dorsal-ventral 
gradient and edge preference albeit with many more cells (Figure 11). However, when 
we looked at the distribution of all ipRGCs using an Melanopsin-Cre;YFP retina, we saw 
no gradient or edge preference (Figure 12) indicating that these are features unique to 
Sst-ipRGCs and other Sst-RGCs. Given the small number of Sst-ipRGCs, it makes sense 
that you do not observe any gradient when looking at ipRGCs altogether. Significant 
further work is necessary to determine whether Sst-ipRGCs actively express Sst in 
adulthood and what functional role these cells play in the visual system 
 
Discussion 
 These studies have begun an already fruitful process of characterizing the full 
neurotransmitter repertoire of ipRGCs. There are readily available Cre lines for 
promising neurotransmitter candidates Corticotropin Releasing Hormone (CRH), Cocaine 
and Amphetamine Responsive Transcipt (CART), Cholecystokinin (CCK), and 
Prodynorphin (Pdyn). Whether we will find 1, 2, or 10 more neurotransmitters employed 
by ipRGCs is still unclear. 
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 Tac1 peptides are promising candidates for explaining the residual pupil 
constriction observed in the absence of glutamate and PACAP. However, in order to 
begin answering that question, we must begin characterizing mice lacking these Tac1 
peptides, preferentially conditionally in ipRGCs. Unfortunately, no conditional Tac1 
allele exists, but a nonconditional Tac1 knockout does (Jax #004103). Assaying PLR in 
these mice and in combination with glutamate and PACAP perturbations is the critical 
next step in understanding a potential active role for Tac1 peptides in the ipRGC system. 
This work is ongoing. 
 The potential function of Sst-ipRGCs is less clear. Determining whether Sst 
expression remains in adulthood and to where in the brain these cells project will be 
critical in uncovering function. In the work that sparked my interest in somatostatin96, 
Sagar and Marshall find Sst-positive ganglion cells in human retinae and propose that 
these cells may equalize signal intensity along the dorsal-ventral axis. The upper portion 
of the visual field is often much brighter than the lower portion resulting in the ventral 
retina receiving higher intensity light than the dorsal retina. These cells could broadly 
dampen signals in the ventral retina to compensate for that fact. Melanopsin would 
provide this system with the ability to stably encode light intensity making this 
explanation particularly appealing.  
 Another important question to consider with Sst-ipRGCs is whether these cells 
are a result of sparse Sst expression in all RGCs and ipRGCs just so happen to be 
included. Any future study of Sst-ipRGCs will need to also investigate the function of 
other Sst-RGCs to see if there is any functional difference between them. If Melanopsin 
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plays no role in the system then it would suggest that Sst-RGC is the functional subtype 
and Sst-ipRGCs are simply a result of the Sst gradient expression program. 
I have only investigated 4 of the 20 ipRGC neurotransmitter candidates (Figure 
3). 2 showed either no expression in the retina generally or in ipRGCs specifically while 
2 others clearly label subsets of ipRGCs. Reporter lines, preferably Cre knockin, are 
critical tool in this candidate approach. 6 more of the neurotransmitter candidates have 
existing and readily available Cre lines, but 10 have none. Given the relative ease of 
allele creation with CRISPR/Cas9, it may prove fruitful to create these remaining lines 
and characterize their expression. Even if no ipRGCs are found to express these 
neuropeptides, we are likely to uncover novel non-ipRGC retinal cell subtypes. 
Methods 
Animal husbandry 
C57Bl/6 × Sv129 hybrid mice were used in all experiments except PACAP KO 
mice which were C57Bl/6. All mice were housed according to guidelines from the 
Animal Care and Use Committee of Johns Hopkins University. Male and female mice 
age 4-8 months were housed in plastic translucent cages with steel-lined lids in an open 
room. Ambient room temperature and humidity were monitored daily and tightly 
controlled. Food and water were available ad libitum. All mice were maintained in a 
12hr:12hr light-dark cycle with light intensity around 100 lux for the entirety of their 
lives. Cre, FLP, and Cre/FLP reporter lines were obtained from Jackson Labs. 
Pupillometry 
All mice were dark-adapted for at least 60 minutes prior to any experiments and 
all PLR experiments were performed between Zeitgeber times (ZT) 2 and 10. For all 
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experiments, mice were unanesthetized and restrained by hand. Because stress can affect 
pupil size, we ensured that the mice were not stressed during these experiments. To do so, 
we handled the mice for several days prior to the experiments to get them accustomed to 
the researchers and to being scruffed. Any mice that showed signs of stress, including 
vocalizations and wriggling during the experiments, were not used and were subjected to 
more handling sessions before use in experiments.  
Mice were restrained manually under a 23-Watt compact fluorescent light bulb 
(GE Daylight FLE10HT3/2/D or Sylvania Daylight CF13EL and CF23EL) with a color 
temperature of 6500 K to simulate natural sunlight. The light intensity was measured 
using a light meter (EXTECH Foot Candle/Lux Light Meter, 401025) at the surface on 
which the mouse was held. The light meter was initially calibrated by EXTECH using a 
Tungsten 2856 K light source; because our experiments used a fluorescent bulb of 6500 
K, all measured light intensities reported here may vary by 0.92–1.12 times the actual 
light intensity.  
Videos of the eye were taken using a Sony Handycam (DCR-HC96) mounted on 
a tripod a fixed distance from the mouse. Manual focus was maintained on the camera to 
ensure that only one focal plane existed for each mouse and that therefore variable 
distance from the camera should not contribute to differences in relative pupil area 
throughout the video. Pupil size was first recorded under dim red light and the 
endogenous infrared light source of the camera to capture the dark-adapted pupil size. 
Following at least 5 seconds of recording in dark, the pupil was continuously recorded for 
at least 30 seconds of a light step stimulus.  
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Videos were transferred from the camera to a computer as Audio Video Interleave 
(AVI) files and individual frames were taken using VLC media player 
(www.videolan.org/vlc/) and saved in portable network graphics format (PNG). Images 
were taken in the dark, at 5 seconds, and 30 seconds following stimulus onset. Pupil area 
was then quantified manually in ImageJ (http://rsbweb.nih.gov/ij/) software. The pupil 
area was measured in pixels using the oval tool in which the 4 cardinal points of the oval 
were touching their respective edges of the pupil. The relative pupil area was calculated 
using LibreOffice Calc or Microsoft Excel in which the area during the light stimulus was 
divided by the area prior to lights onset. For the transient PLR, the minimum relative 
pupil size after stimulus was used for all genotypes. 
 
Viral infection 
Mice were anesthetized by intraperitoneal injection of avertin (2, 2, 2-
Tribromoethanol) and placed under a stereo microscope. 1 μl of AAV2-hSyn-DIO-
hM3DGq-mCherry (4.6 × 10
12 viral particles/ml, Roth lab, UNC Vector Core) was placed 
on a piece of Parafilm and drawn into a 10-μl microcapillary tube (Sigma P0674) that had 
been pulled to a needle (Sutter Instruments, Model P-2000). The loaded needle was then 
placed in the holster of a pico-injector (Harvard Apparatus PLI-90). The needle 
punctured the eye posterior to the ora serrata and air pressure was used to drive the viral 
solution into the vitreous chamber of the eye to ensure delivery specifically to the retina. 
Mice recovered from surgery on a heating pad until they woke from anesthesia. All 




Immunofluorescence and confocal microscopy 
Mice were anesthetized with avertin and then euthanized using cervical 
dislocation. The eyes were removed and the retinas were dissected in PBS and then fixed 
in 4% paraformaldehyde for 1–2 hours on ice. When brain sections were necessary, mice 
were perfused. The retinas were then washed in PBS at least three times before mounting 
on a microscope slide (Fisher) in Fluoromount (Sigma). Some retinas were co-stained for 
melanopsin or RBPMS using rabbit anti-OPN4 (Advanced Targeting Systems, AB-N38, 
1:1000) or rabbit anti-RBPMS (Millipore ABN1362) in 4% goat serum with secondary 
antibody Alexa Fluor 594 goat anti-rabbit (Life Technologies A11008, 1:1000). YFP 
signal in reporter retinas was boosted by immunostaining with chicken anti-GFP (abcam 
ab13970) followed by secondary Alexa Fluor 488 goat anti-chicken. Images were taken 
on a Zeiss LSM 710 confocal microscope using a 20X or 63X objective.  For imaging of 
whole retinas for determining cell distributions, tilescans were performed followed by 
stitching with Zeiss Zen Blue software. 
 
Retinal distribution 
 Cell positions were determined by a custom MATLAB script. Results of this 
process were cross-checked by hand to avoid gross errors. Cell distribution along the 
dorsal-ventral and nasal-temporal axes was again determined via custom MATLAB script 
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Figure 1: PLR persists in the absence of glutamate and PACAP. 
Transient pupil constriction in response to high white light (1000 lux, 6500K).Y-axis is 
relative pupil area (pupil size in light/pupil size before light). Individual points represent 
separate mice and bars are the mean. Opn4Cre;TeNT mice possess silenced ipRGCs 
lacking all neurotransmission and showed no pupil constriction in response to light. 
PACAP KO (Adcyap1-/-) and ipRGC glu.-KO (Vglut2 KO) mice display PLR thoroughly 
described in Chapter 2. ipRGC glutamate/PACAP double KO 
(Opn4Cre;Vglut2fl/fl;Adcyap1-/-) responses were similar to ipRGC glu. KO (P=0.95), but 








Figure 2: Schematic of inputs and outputs of the ipRGC system.  
IpRGCs receive input from 3 photosensors: rods, cones, and Melanopsin (See Chapter 2 
for detailed characterization of their individual contributions). Given the remaining 
responses in mice lacking the 2 known ipRGC outputs, glutamate and PACAP, there 








Figure 3: Candidate ipRGC neurotransmitters.  
Diagram of potential novel ipRGC neurotransmitters. Twenty neurotransmitters have 
sufficient evidence to warrant further investigation. Of these, 9 have readily available 
Cre-knockin lines (Green) or transgenic reporter lines (Yellow). An Avp Cre line (Red) 
was briefly investigated but no signal was seen in the retina (data not shown). Of the 9 
lines obtained, 2 did not produce reporter offspring (red outline: Penk1 and Oxt) and 










Figure 4: Neuropeptide Y does not label Melanopsin antibody positive cells.  
Antibody staining in NPY reporter (transgenic NPY-GFP) wholemount retina. (A) NPY 
reporter expression in the GCL and INL. Sparse cell populations in both layers. (B) 
RBPMS (labels all ganglion cells) antibody staining in a wholemount NPY reporter retina 
(GCL). The vast majority of NPY reporter positive cells in the GCL are not RPMS 
positive although a small number of weakly positive cells can be observed. (C) 
Melanopsin antibody staining in a wholemount NPY reporter retina (GCL). No 











Figure 5: Tachykinin 1 reporter mice label ipRGCs and expression persists to 
adulthood.  
Antibody staining in Tac1 reporter (Tac1IRES-Cre) wholemount retina. (A) Tac1 reporter 
expression in the GCL and colocalization with ganglion cell marker RBPMS. Cells of 
nearly all types are labeled sparsely including ganglion cells. The arrow indicates a Tac1-
positive RGC. (B) Melanopsin antibody staining in a wholemount Tac1 reporter retina 
(GCL). Several Melanopsin-positive cells are Tac1-positive (red arrows). (C) Tac1-
positive ipRGCs maintain Cre expression into adulthood. High magnification image of 
Tac1-positive ipRGC infected with AAV2-DIO-DREADD-mCherry. (Blue – mCherry 







Figure 6: Tac1-positive ipRGCs project to the olivary pretectal nucleus (OPN). 
Tac1-positive ipRGC tracing using the mCherry signal from AAV2-DIO-DREADD-
mCherry. The suprachiasmatic nucleus (SCN) and superior colliculus (SC) had no 
obvious innervation. The lateral geniculate nucleus (LGN) had sparse innervation and the 












Figure 7: Somatostatin Cre reporter mice label a subset of ipRGCs. 
 Antibody staining in Sst reporter (SstIRES-Cre) wholemount retina. (A) Sst reporter 
expression in the GCL and colocalization with ganglion cell marker RBPMS. The vast 
majority of Sst-reporter positive cells are ganglion cells in the GCL. The arrows indicate 
example Sst-positive RGC. (B) Melanopsin antibody staining in a wholemount Sst 
reporter retina (GCL). (top) Rare Sst-positive ipRGCs are present (red arrow). (bottom) 
Another example of a Sst-positive ipRGC. (Magenta – antibody)(Green – SstCre;YFP 








Figure 8: A small subset of horizontal cells are labeled by Somatostatin Cre. 
 34 labeled horizontal cells in the retina counted. (left) 2 labeled Sst-positive horizontal 







Figure 9: Intersectional approach to label Sst-ipRGCs.  
(A) The RC::FLTG mouse line allows for intersectional labelling of cell subtypes using 
Cre and FLP systems. (top) Genetic schematic of RC::FLTG allele. FLP mediates 
excision of the FRT-flanked STOP allowing for tdTomato expression. Cre mediates 
excision of LoxP-flanked tdTomato-STOP. Cre and FLP lead to eGFP expression. 
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(bottom) Graphical description of reporter outcomes. (B) Opn4Cre;SstFLP;RC::FLTG mice 
label Sst-FLP only cells (magenta) and Sst-FLP/Opn4-Cre double positive Sst-ipRGCs 







Figure 10: Sst-ipRGCs inhabit the ventral retinal edges.  
Heatmap shows distribution of Sst-ipRGCs (FLP/Cre double positive) along dorsal-
ventral (right) and nasal-temporal (bottom) axes. Yellow/white indicates more cells – red 
indicates less. For each cell, the distance to the retinal edge was calculated in microns. 






Figure 11: All Sst-positive non-ipRGCs also cluster at the edge of the ventral retina. 
Heatmap shows distribution of Sst-positive cells (FLP positive ONLY) along dorsal-
ventral (right) and nasal-temporal (bottom) axes. Yellow/white indicates more cells – red 
indicates less. For each cell, the distance to the retinal edge was calculated in microns. 





Figure 12: Total ipRGC population inhabit the whole retina with little to no 
preference for the retinal edge. 
 Heatmap shows distribution of ipRGCs (Opn4Cre ; YFP+ cells) along dorsal-ventral 
(right) and nasal-temporal (bottom) axes. For each cell, the distance to the retinal edge 
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Designer Receptors Exclusively Activated by Designer Drugs (DREADD) are an 
important tool for modulating and understanding neural circuits. DREADD-targeted 
neurons can be activated or repressed, depending on the DREADD type, in vivo 
following a dose of the DREADD agonist clozapine-n-oxide (CNO). Because DREADD 
experiments often involve behavioral assays, the method of CNO delivery is important. 
Currently, the most common delivery method is intraperitoneal (IP) injection. IP injection 
is both a fast and reliable technique, but it is painful and potentially stressful particularly 
when many injections are required. We sought an alternative CNO delivery paradigm, 
which would retain the speed and reliability of IP injections without being as invasive, 
painful or stressful. Here we show that CNO can be effectively delivered topically via 
eye-drops.  Eye-drops robustly activated DREADD-expressing neurons in the brain and 
peripheral tissues and does so at the same dosages as IP injection. Eye-drops provide an 
easier, less invasive and less stressful method for activating DREADDs in vivo.  
 
Introduction 
Scientists have developed a variety of methods to modulate targeted neuronal 
subpopulation in vivo to understand the neuronal circuits underlying behavior. Two such 
methods have become commonplace in modern neuroscience: chemogenetics and 
optogenetics.  Both techniques rely on engineered proteins responsive to either chemical 
agonists in the case of chemogenetics or photons in the case of optogenetics.  
A variety of chemogenetic tools have been developed over the past two decades, 
and have been recently reviewed 106,107. However, a class named Designer Receptors 
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Exclusively Activated by Designer Drugs or DREADDs have emerged as the primary 
chemogenetic tool for modulation of specific cell types70. The principal DREADDs used 
today are the activity enhancing Gq-coupled hM3Dq receptor and the Gi-coupled hM4Di 
receptor (Gq-DREADD and Gi-DREADD)
70. DREADDs can be introduced virally or 
using an expanding collection of transgenic mice108–112. Both engineered receptors are 
activated by the chemical clozapine-n-oxide (CNO), and are being used to robustly 
modulate a variety of neuronal populations in vivo 94,113–116. Additional CNO-responsive 
receptors have been engineered to activate Gs signaling
112, arrestin signaling117, and axon 
specific Gi signaling
118. 
The primary advantage of the DREADD approach is that it can be used in live 
behaving animals without any need for complex equipment—optogenetics, for instance, 
requires delivering intense light to a particular brain reqion which often involves surgical 
implantation of an optical fiber. For in vivo studies using DREADDs, activation only 
requires delivery of CNO to the subject’s blood, which will eventually reach target 
neurons. While CNO is typically administered by IP injection, it has also been delivered 
in drinking water119 and by implanted minipumps120. IP injection provides fine control 
over exact dosage and dose timing while drinking water and minipump approaches allow 
for chronic dosage without constant handling. However, each delivery method has 
disadvantages—IP injection causes both stress and pain which are undesirable when 
investigating animal behavior, particularly when studying aspects of behavior directly 
impacted by stress and pain. CNO in drinking water alleviates the confound of stress/pain 
but you lose control over precise dosage and dose timing. Additionally, increased costs 
associated with the large quantities of CNO required for dosing drinking water is also a 
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limitation. The implanted minipump approach retains dosage control and allows for 
chronic administration, however this is achieved at the cost of requiring surgery and 
specialized equipment. 
We endeavored to find and characterize a novel method of CNO delivery which 
alleviates some of the difficulties of currently used techniques. An often-used method of 
self-administration in humans is topical administration by eye-drops and subsequent 
absorption into the blood. Eye-drops are a non-invasive painless way of achieving precise 
dosage as well as dose timing. Eye-drop drug delivery has the added benefits of being 
exceptionally easy to perform as well as not requiring any additional equipment such as 
syringes. 
In this study, we first confirmed the capability of CNO eye-drops to activate 
DREADD-expressing neurons in the brain. Next, to investigate the feasibility of eye-drop 
CNO delivery in vivo, we utilized a subpopulation of retinal ganglion cells, intrinsically 
photosensitive retinal ganglion cells (ipRGCs), which drive robust and quantifiable pupil 
constriction when activated by light12,13,121 or DREADDs94,122. In this study, we report 
that CNO can be delivered by eye-drop to activate DREADDs in vivo. Additionally, we 
have determined the dose-response relationship and relative bioavailability of CNO 
delivered via eye-drop and IP injection.  
 
Materials and Methods 
Animal husbandry 
C57Bl/6 × Sv129 hybrid mice were used in all experiments. All mice were 
housed according to guidelines from the Animal Care and Use Committee of Johns 
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Hopkins University. Male and female mice age 2–8 months were housed in plastic 
translucent cages with steel-lined lids in an open room. Ambient room temperature and 
humidity were monitored daily and tightly controlled. Food and water were available ad 
libitum. All mice were maintained in a 12hr:12hr light-dark cycle with light intensity 
around 100 lux for the entirety of their lives.  
 
Drug preparation 
 Clozapine-n-oxide (CNO, Sigma-Aldrich SKU:C0832-5MG) was dissolved in 
sterile 0.9% saline solution. CNO/saline solution was then diluted to achieve the dosage 
(mg/kg) per mouse required for the experiment. 
 
CNO delivery 
 CNO was delivered either by eye-drop or intraperitoneal injection (IP). For eye-
drops, CNO was diluted based on mouse weight to achieve the correct dose within a 1-2 
microliter dose. 1-2 μl was then loaded into P10 micropipette followed by immobilizing 
the mouse via scruff. The 1-2 μl range was chosen because it is large enough to be 
accurately pipetted and small enough to not drip off of the eye after application. The 
solution in the pipette was then expelled slowly so that a stable droplet forms on the 
pipette tip. The droplet was then carefully touched to the cornea of the mouse eye and the 





All mice were dark-adapted for at least 30 minutes prior to CNO delivery and 
subsequent pupil measurements. For all experiments, mice were unanesthetized and 
restrained by hand. Videos of the eye were taken using a Sony Handycam (FDR-AX33) 
mounted on a tripod a fixed distance from the mouse. Manual focus was maintained on 
the camera to ensure that only one focal plane existed for each mouse and that therefore 
variable distance from the camera should not contribute to differences in relative pupil 
area throughout the video. Pupil size was first recorded under dim red light and the 
endogenous infrared light source of the camera to capture the dark-adapted baseline pupil 
size. CNO was then delivered as an eye-drop or injection and the mouse was returned to 
their cage. Pupil size was monitored at intervals described in the results section. All pupil 
images presented in the paper were cropped to a fixed square area surrounding the eye 
using GNU Image Manipulation Program (GIMP). The images were made grayscale and 
then brightness and contrast were adjusted to enhance visibility of the pupil and exported 
as PNG files.  
 
Data analysis  
Videos were transferred from the camera to a computer as Audio Video Interleave 
(AVI) files and individual frames were taken using VLC media player 
(www.videolan.org/vlc/) and saved in portable network graphics format (PNG). Images 
were taken in the dark. Pupil area was then quantified manually in ImageJ 
(http://rsbweb.nih.gov/ij/) software. The pupil area was measured in pixels using the oval 
tool in which the 4 cardinal points of the oval were touching their respective edges of the 
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pupil. The relative pupil area was calculated using Microsoft Excel in which the area 
during the stimulus was divided by the area prior to CNO dosage.  
The dose-response curve was fit using a variable slope sigmoidal dose-response 
curve in Graphpad Prism 6. The top and bottom of the fit were constrained to 1.0 and 
between 0 and 0.10, respectively. 
 
Viral infection 
For viral infection of the retina, Opn4Cre 88 and littermate control mice were 
anesthetized by IP injection of avertin (2, 2, 2-Tribromoethanol) and placed under a 
stereo microscope. 1 μl of adeno-associated virus (AAV)2-hSyn-DIO-hM3DGq-mCherry 
(4.6 × 1012 viral particles/ml, Roth lab, UNC Vector Core) was placed on a piece of 
Parafilm and drawn into a 10-μl microcapillary tube (Sigma P0674) that had been pulled 
to a needle (Sutter Instruments, Model P-2000). The loaded needle was then placed in the 
holster of a pico-injector (Harvard Apparatus PLI-90). The needle punctured the eye 
posterior to the ora serrata and air pressure was used to drive the viral solution into the 
vitreous chamber of the eye to ensure delivery specifically to the retina. Mice recovered 
from surgery on a heating pad until they woke from anesthesia. All experiments were 
performed 3-5 weeks following viral injection. 
For viral infection of the brain, mice were deeply anesthetized by IP injection of 
avertin, and rAAV5-hSyn-hM3D(Gq)-mCherry (3.4 × 10¹² viral particles/ml, Roth lab, 
UNC Vector Core) was stereotaxically delivered. All coordinates used follow the Paxinos 
and Franklin atlas 123. A 10-μl microcapillary pipette was pulled and loaded with the 
AAV solution. A total volume of ~100 nl of AAV was injected using a microinjector 
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(Nanojector II, Drummond Scientific Company). A heating pad was used to maintain the 
body temperature at ~35◦C. Before and after the surgery, systemic analgetics 
(buprenorphine, 0.1 mg/kg) were administrated. 
 
Immunofluorescence and confocal microscopy 
Four weeks after brain injections, cFos induction (in AAV-infected neurons) was 
immunohistochemically evaluated in mice that were perfused 2 hours after application of 
an eye-drop of CNO (~0.5 mg/kg dose); mice were kept in constant darkness during the 
experiment. After perfusion, brains were post-fixed overnight, and subsequently 
sectioned on a cryostat (coronal sections, 40 μm). Brain sections were blocked for 2 
hours in PBS containing 0.3% Triton X-100 and 3% heat-inactivated goat serum and then 
incubated using a mouse IgG1 α-cFos (EnCor MCA-2H2; 1:500) and a rabbit IgG α-RFP 
(red fluorescent protein, MBL PM005; 1:1000) overnight, at 4°C. The following 
secondary antibodies were used (1:200; Molecular Probes): goat anti-rabbit Alexa 546; 
and goat anti-mouse IgG1 Alexa 488. Finally, slides were mounted in AntiFade medium 
(Molecular Probes). Images were acquired using a LSM-700 confocal microscope 
(Zeiss). For all morphometric image processing, digitized captured TIF-images were 




All statistical tests were performed in Graphpad Prism 6. Specific statistical 
comparisons are listed in the figure captions. Because the EC50 data appears to be a 
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normal distribution on a log scale (log-normal distribution), all statistical tests and data 
analysis involving EC50 were performed on the log transformed data set. 
 
Results 
Eye-drop CNO activates DREADDs in the brain 
 We first sought to confirm that CNO eye-drops effectively activate DREADDs in 
the brain. To do so, we injected a Gq-DREADD-containing virus (AAV5-hSyn-
hM3D(Gq)-mCherry) into a well-studied nucleus of the thalamus, the paraventricular 
nucleus (PVT) (Figure 1A). Four weeks following viral injection, we applied an eye-
drop of CNO (~0.5 mg/kg) and evaluated neuronal activation 2 hours afterward by 
assaying the expression of the immediate early-gene cFos. Using the DREADD-mCherry 
fusion protein to identify virally infected cells, we observed robust cFos staining in 
neurons expressing the DREADD-mCherry reporter, indicating that the CNO eye-drop 
had successfully activated Gq-DREADD in those cells (Figure 1B-D, another example at 
higher magnification-Figure 1E-G). No cFos activation was observed when cells were 
infected with a virus expressing mCherry alone (data not shown). This result confirms the 
ability of CNO delivered by eye-drop to enter the blood and activate DREADDs in the 
brain. However, this approach does not allow us to quantitatively compare the 
effectiveness of eye-drops to IP injection in vivo.  
 
Eye-drop delivery of CNO activates DREADDs in vivo 
 To visualize and quantify DREADD activity in vivo, we utilized a genetically 
defined subpopulation of melanopsin expressing retinal ganglion cells, intrinsically 
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photosensitive retinal ganglion cells ipRGCs (ipRGCs), which we and others have shown 
to drive pupil constriction when activated by Gq-DREADD
94,122. This system gives us a 
readily observable and easily quantifiable output of DREADD activation in vivo. The 
Opn4Cre (Opn4 → Melanopsin) mouse88 gives us genetic access to these cells and a Cre-
dependent Gq-DREADD adeno-associated virus (AAV) allows us to specifically express 
Gq-DREADD in ipRGCs.  
 We first injected an AAV carrying a Cre-dependent Gq-DREADD construct 
(AAV2-hSyn-DIO-hM3DGq-mCherry) into only the right eye of Opn4
Cre mice, leaving 
the left eye uninfected (Figure 2A). Using this system, 3 to 5 weeks after infection, we 
applied a 1 μl CNO (0.1 mg/kg) eye-drop to the uninfected left eye. We observed robust 
pupil constriction (Figure 2B) as has been observed previously in response to IP 
CNO94,122. This result further demonstrates that CNO delivered via eye-drop is absorbed 
into the blood and delivered to distant tissues at working concentrations in vivo. 
 
Eye-drop and IP injection evoked responses have similar dose efficiency 
 After confirming the feasibility of eye-drops as a delivery method, we next 
compared the CNO doses required to elicit responses when using eye-drop or IP delivery 
(Figure 2C,D). To do so, we administered doses of 0.001, 0.01, 0.1, and 1.0 mg/kg CNO 
via eye-drop or IP injection and monitored pupil constriction (Figure 2C, n = 10). We 
observed similar dose responses for both methods, with eye-drops displaying a small but 
statistically significant decrease in the dose required to achieve half-maximal response 
(EC50) (Figure 2D, P = 0.0195 by Wilcoxon matched-pairs signed rank test). This 
difference could be explained by changes in blood absorption efficiency or potentially by 
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reduced stress responses in these mice after eye-drop as opposed to IP injection. 
However, the magnitude of the difference is minor and essentially irrelevant when 
considering the practical application of either technique. 
 
Discussion 
 We have shown that eye-drops are an effective way to deliver CNO and activate 
DREADDs for in vivo studies. Eye-drops offer an alternative to current CNO delivery 
methods: drinking water and IP injection. When chronic DREADD activation is 
necessary and dose timing is unimportant, drinking water still provides the best dosing 
method. However, in the majority of DREADD experiments in which IP injection would 
be used, our method provides several advantages: (1) ease of application, (2) non-
invasive, (3) less pain and stress, (4) cost/waste reduction (no syringes).   
 We hope that the widespread use of eye-drops in the place of IP injection will 
further simplify performing DREADD experiments and significantly reduce the distress 
inflicted on test subjects during in vivo experimentation. 
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Figure 1: CNO eye-drops activate DREADDs in the brain 
(A) Experimental approach. The effects of a single eye-drop of clozapine-N-oxide (CNO) 
were evaluated in wild-type mice stereotaxically injected in the paraventricular nucleus of 
the thalamus (PVT) with an AAV5-Gq-DREADD-mCherry. Four weeks after AAV 
injection, a single eye-drop of CNO was administrated (2 μl, 5mg CNO/ml) and 2 hours 
later the cFos induction was evaluated. Mouse brain schematic with AAV injection site 
highlighted. (B) mCherry expression confirms DREADD expression and cFos staining (C) 
shows cell activation in response to a CNO eye-drop. (D) Colocalization of mCherry 
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expression and cFos staining, indicating activation of infected-cells in response to CNO. 
(E-G) DREADD activation in response to a CNO eye-drop is shown at higher 
magnification. In all cases, a strong cFos induction was observed exclusively in infected 






Figure 2: Eye-drop administration of CNO activates DREADDs in vivo similar to IP 
(A) Depiction of experimental approach. An AAV carrying a Cre-dependent Gq-
DREADD was injected into the right eye of mice with Cre expression in ipRGCs 
(Opn4Cre mice). 3-5 weeks later, CNO was administered by eye-drop to the left eye. (B) 
DREADD activation is visualized by measuring pupil constriction in response to 1 μl 
CNO (1 mg/kg). (left) Baseline pupil size before CNO. (right) Pupil constriction 
observed in response to CNO applied directly to the left uninfected eye. (C) Dose-
response curves for CNO applied via IP injection or eye-drop. All mice had Gq-
DREADD expression only in the right eye and eye-drops were delivered to the left eye. 
Four doses were administered spanning the dynamic range: 0.001, 0.01, 0.1, and 1.0 
mg/kg. Data fit with a sigmoidal curve (n = 10, mean ± SD). (D) CNO dose required for 
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half-maximal constriction (EC50) determined for both eye-drop and IP injection. EC50 
extracted from the sigmoidal curve fits for each mouse (points are individual mice, lines 
connect EC50 values for the same mouse). Statistical significance determined by a 










In the preceding chapters, I have shed light on several aspects of ipRGC sensory 
processing and signaling. focused on two separate but inter-dependent aspects of ipRGC 
sensory function: light information gathering/integration and light information 
communication. Using the PLR as a model behavior, I have provided evidence that the 
rod photoreceptor and glutamatergic neurotransmission support rapid changes to 
fluctuations in environmental light, while Melanopsin phototransduction and 
PACAPergic neurotransmission support steady state long-term signaling of ambient light 
intensity. I have shown that pupil dilation is an active process driven my glutamatergic 
neurotransmission from ipRGCs. Lastly, I have discovered two novel ipRGC 
neurotransmitters and identified several promising candidates for future investigation. I 
hope that this work will provide a strong base for future research in the Hattar lab and the 
field at large. 
 
Neurotransmitters in the retina 
 In my view, the investigation I have begun into novel neurotransmitter systems is 
the most promising for future work. After a burst of work in the 80s and 90s discovering 
a variety of neuropeptides expressed in the retina, very little follow up has been done to 
characterize the role of these neurotransmitter systems. Given the tools developed since 
then, there are an immense amount of fairly easy questions to answer. 
 The idea that RGCs communicate visual information with glutamate alone is 
certainly an incomplete one.  My work on 3 neuropeptides has revealed novel RGC 
populations expressing each. Further work on more neuropeptides is likely to reveal 
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widespread expression of neuropeptides in RGCs. Understanding the role these 
neuropeptides play in conveying light information to the brain is going to be critical for 
understanding image forming and non-image forming vision.   Specific populations of 
RGCs are known to detect and convey unique aspects of the visual field. It is likely that 
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